1	O
,	O
25-Dihydroxyvitamin	O
D3	O
induces	O
differentiation	O
of	O
a	O
retinoic	B-cell_line
acid-resistant	I-cell_line
acute	I-cell_line
promyelocytic	I-cell_line
leukemia	I-cell_line
cell	I-cell_line
line	I-cell_line
(	O
UF-1	B-cell_line
)	O
associated	O
with	O
expression	O
of	O
p21	B-protein
(	I-protein
WAF1/CIP1	I-protein
)	I-protein
and	O
p27	B-protein
(	I-protein
KIP1	I-protein
)	I-protein
.	O

Retinoic	O
acid	O
(	O
RA	O
)	O
resistance	O
is	O
a	O
serious	O
problem	O
for	O
patients	O
with	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
who	O
are	O
receiving	O
all-trans	O
RA	O
.	O

However	O
,	O
the	O
mechanisms	O
and	O
strategies	O
to	O
overcome	O
RA	O
resistance	O
by	O
APL	B-cell_type
cells	I-cell_type
are	O
still	O
unclear	O
.	O

The	O
biologic	O
effects	O
of	O
RA	O
are	O
mediated	O
by	O
two	O
distinct	O
families	O
of	O
transcriptional	B-protein
factors	I-protein
:	O
RA	B-protein
receptors	I-protein
(	O
RARs	B-protein
)	O
and	O
retinoid	B-protein
X	I-protein
receptors	I-protein
(	O
RXRs	B-protein
)	O
.	O

RXRs	B-protein
heterodimerize	O
with	O
1	B-protein
,	I-protein
25-dihydroxyvitamin	I-protein
D3	I-protein
[	I-protein
1	I-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
]	I-protein
receptor	I-protein
(	O
VDR	B-protein
)	O
,	O
enabling	O
their	O
efficient	O
transcriptional	O
activation	O
.	O

The	O
cyclin-dependent	B-protein
kinase	I-protein
(	I-protein
cdk	I-protein
)	I-protein
inhibitor	I-protein
p21	B-protein
(	I-protein
WAF1/CIP1	I-protein
)	I-protein
has	O
a	O
vitamin	B-DNA
D3-responsive	I-DNA
element	I-DNA
(	O
VDRE	B-DNA
)	O
in	O
its	O
promoter	B-DNA
,	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
enhances	O
the	O
expression	O
of	O
p21	B-protein
(	I-protein
WAF1/CIP1	I-protein
)	I-protein
and	O
induces	O
differentiation	O
of	O
selected	O
myeloid	B-cell_line
leukemic	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

We	O
have	O
recently	O
established	O
a	O
novel	O
APL	B-cell_line
cell	I-cell_line
line	I-cell_line
(	O
UF-1	B-cell_line
)	O
with	O
features	O
of	O
RA	O
resistance	O
.	O

1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
can	O
induce	O
growth	O
inhibition	O
and	O
G1	O
arrest	O
of	O
UF-1	B-cell_line
cells	I-cell_line
,	O
resulting	O
in	O
differentiation	O
of	O
these	O
cells	O
toward	O
granulocytes	B-cell_type
.	O

This	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3-induced	O
G1	O
arrest	O
is	O
enhanced	O
by	O
all-trans	O
RA	O
.	O

Also	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
(	O
10	O
(	O
-10	O
)	O
to	O
10	O
(	O
-7	O
)	O
mol/L	O
)	O
in	O
combination	O
with	O
RA	O
markedly	O
inhibits	O
cellular	O
proliferation	O
in	O
a	O
dose-	O
and	O
time-dependent	O
manner	O
.	O

Associated	O
with	O
these	O
findings	O
,	O
the	O
levels	O
of	O
p21	B-protein
(	I-protein
WAF1/CIP1	I-protein
)	I-protein
and	O
p27	B-RNA
(	I-RNA
KIP1	I-RNA
)	I-RNA
mRNA	I-RNA
and	O
protein	O
increased	O
in	O
these	O
cells	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
p21	B-RNA
(	I-RNA
WAF1/CIP1	I-RNA
)	I-RNA
and	I-RNA
p27	I-RNA
(	I-RNA
KIP1	I-RNA
)	I-RNA
mRNA	I-RNA
and	O
protein	O
increased	O
in	O
these	O
cells	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
p21	B-protein
(	I-protein
WAF1/CIP1	I-protein
)	I-protein
and	O
p27	B-protein
(	I-protein
KIP1	I-protein
)	I-protein
transcripts	O
were	O
induced	O
after	O
6	O
hours	O
'	O
exposure	O
to	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
and	O
then	O
decreased	O
to	O
basal	O
levels	O
over	O
48	O
hours	O
.	O

Western	O
blot	O
experiments	O
showed	O
that	O
p21	B-protein
(	I-protein
WAF1/CIP1	I-protein
)	I-protein
protein	O
levels	O
increased	O
and	O
became	O
detectable	O
after	O
12	O
hours	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
treatment	O
and	O
induction	O
of	O
p27	B-protein
(	I-protein
KIP1	I-protein
)	I-protein
protein	O
was	O
much	O
more	O
gradual	O
and	O
sustained	O
in	O
UF-1	B-cell_line
cells	I-cell_line
.	O

Interestingly	O
,	O
the	O
combination	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
and	O
RA	O
markedly	O
enhanced	O
the	O
levels	O
of	O
p27	B-protein
(	I-protein
KIP1	I-protein
)	I-protein
transcript	O
and	O
protein	O
as	O
compared	O
with	O
levels	O
induced	O
by	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
alone	O
.	O

In	O
addition	O
,	O
exogenous	O
p27	B-protein
(	I-protein
KIP1	I-protein
)	I-protein
expression	O
can	O
enhance	O
the	O
level	O
of	O
CD11b	B-protein
antigen	I-protein
in	O
myeloid	B-cell_type
leukemic	I-cell_type
cells	I-cell_type
.	O

In	O
contrast	O
,	O
RA	O
alone	O
can	O
induce	O
G1	O
arrest	O
of	O
UF-1	B-cell_line
cells	I-cell_line
;	O
however	O
,	O
it	O
did	O
not	O
result	O
in	O
an	O
increase	O
of	O
p21	B-protein
(	I-protein
WAF1/CIP1	I-protein
)	I-protein
and	O
p27	B-protein
(	I-protein
KIP1	I-protein
)	I-protein
transcript	O
and	O
protein	O
expression	O
in	O
RA-resistant	O
cells	O
.	O

Taken	O
together	O
,	O
we	O
conclude	O
that	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
induces	O
increased	O
expression	O
of	O
cdk	B-protein
inhibitors	I-protein
,	O
which	O
mediates	O
a	O
G1	O
arrest	O
,	O
and	O
this	O
may	O
be	O
associated	O
with	O
differentiation	O
of	O
RA-resistant	O
UF-1	B-cell_line
cells	I-cell_line
toward	O
mature	O
granulocytes	B-cell_type
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIESIS	NULL
1,25-Dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
Induces	NULL
Differentiation	NULL
of	NULL
a	NULL
Retinoic	NULL
Acid-Resistant	NULL
Acute	NULL
Promyelocytic	NULL
Leukemia	NULL
Cell	NULL
Line	NULL
(	NULL
UF-1	NULL
)	NULL
Associated	NULL
With	NULL
Expression	NULL
Of	NULL
p21WAF1/CIP1	NULL
and	NULL
p27KIP1	NULL
By	NULL
Akihiro	NULL
Muto	NULL
,	NULL
Masahiro	NULL
Kizaki	NULL
,	NULL
Kenji	NULL
Yamato	NULL
,	NULL
Yohko	NULL
Kawai	NULL
,	NULL
Maiko	NULL
Kamata-Matsushita	NULL
,	NULL
Hironori	NULL
Ueno	NULL
,	NULL
Masahiro	NULL
Ohguchi	NULL
,	NULL
Tatsuji	NULL
Nishihara	NULL
,	NULL
H.	NULL
Phillip	NULL
Koeffler	NULL
,	NULL
and	NULL
Yasuo	NULL
Ikeda	NULL
Retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
resistance	NULL
is	NULL
a	NULL
serious	NULL
problem	NULL
for	NULL
patients	NULL
with	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
who	NULL
are	NULL
receiving	NULL
all-trans	NULL
RA	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
and	NULL
strategies	NULL
to	NULL
overcome	NULL
RA	NULL
resistance	NULL
by	NULL
APL	NULL
cells	NULL
are	NULL
still	NULL
unclear	NULL
.	NULL

The	NULL
biologic	NULL
effects	NULL
of	NULL
RA	NULL
are	NULL
mediated	NULL
by	NULL
two	NULL
distinct	NULL
families	NULL
of	NULL
transcriptional	NULL
factors	NULL
:	NULL
RA	NULL
receptors	NULL
(	NULL
RARs	NULL
)	NULL
and	NULL
retinoid	NULL
X	NULL
receptors	NULL
(	NULL
RXRs	NULL
)	NULL
.	NULL

RXRs	NULL
heterodimerize	NULL
with	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
[	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
]	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
,	NULL
enabling	NULL
their	NULL
efficient	NULL
transcriptional	NULL
activation	NULL
.	NULL

The	NULL
cyclin-dependent	NULL
kinase	NULL
(	NULL
cdk	NULL
)	NULL
inhibitor	NULL
p214	NULL
``	NULL
``	NULL
Â°	NULL
``	NULL
``	NULL
has	NULL
a	NULL
vitamin	NULL
D	NULL
;	NULL
-responsive	NULL
element	NULL
(	NULL
V	NULL
DRE	NULL
)	NULL
in	NULL
its	NULL
promoter	NULL
,	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
p21	NULL
4	NULL
``	NULL
and	NULL
induces	NULL
differentiation	NULL
of	NULL
selected	NULL
myeloid	NULL
leukemic	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
established	NULL
a	NULL
novel	NULL
APL	NULL
cell	NULL
line	NULL
(	NULL
UF-1	NULL
)	NULL
w	NULL
ith	NULL
features	NULL
of	NULL
RA	NULL
resistance	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
can	NULL
induce	NULL
growth	NULL
inhibition	NULL
and	NULL
G1	NULL
arrest	NULL
of	NULL
UF-1	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
toward	NULL
granulocytes	NULL
.	NULL

This	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-induced	NULL
G1	NULL
arrest	NULL
is	NULL
enhanced	NULL
by	NULL
all-trans	NULL
RA	NULL
.	NULL

Also	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
10-	NULL
'	NULL
mol/l	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
RA	NULL
markedly	NULL
inhibits	NULL
cellular	NULL
proliferation	NULL
in	NULL
a	NULL
dose-	NULL
and	NULL
time-dependent	NULL
manner	NULL
.	NULL

Associated	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
p21	NULL
``	NULL
4	NULL
``	NULL
and	NULL
p27	NULL
``	NULL
mRNA	NULL
and	NULL
protein	NULL
increased	NULL
in	NULL
these	NULL
ETINOIC	NULL
ACID	NULL
(	NULL
RA	NULL
)	NULL
and	NULL
vitamin	NULL
D	NULL
;	NULL
,	NULL
have	NULL
profound	NULL
effects	NULL
on	NULL
the	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

!	NULL
``	NULL

All-frans	NULL
RA	NULL
and	NULL
its	NULL
stereoisomer	NULL
,	NULL
9-cis	NULL
RA	NULL
,	NULL
induce	NULL
differentiation	NULL
and	NULL
inhibit	NULL
proliferation	NULL
of	NULL
human	NULL
leukemic	NULL
cell	NULL
lines	NULL
such	NULL
as	NULL
HL-60	NULL
cells	NULL
and	NULL
fresh	NULL
leukemic	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
1,25-Dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
[	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
]	NULL
is	NULL
a	NULL
biologic	NULL
active	NULL
form	NULL
of	NULL
vitamin	NULL
D	NULL
;	NULL
that	NULL
functions	NULL
primarily	NULL
in	NULL
calcium	NULL
homeostasis	NULL
in	NULL
vitro	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
can	NULL
also	NULL
induce	NULL
some	NULL
myeloid	NULL
leukemic	NULL
cell	NULL
lines	NULL
to	NULL
differentiate	NULL
along	NULL
the	NULL
monocyte/macrophage	NULL
pathway	NULL
and	NULL
can	NULL
prolong	NULL
the	NULL
survival	NULL
of	NULL
leukemic	NULL
mice	NULL
.	NULL

``	NULL
*	NULL
These	NULL
biologic	NULL
effects	NULL
of	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
are	NULL
mediated	NULL
by	NULL
their	NULL
respective	NULL
nuclear	NULL
receptors	NULL
,	NULL
retinoic	NULL
acid	NULL
receptor	NULL
(	NULL
RAR	NULL
)	NULL
,	NULL
retinoid	NULL
X	NULL
receptor	NULL
(	NULL
RXR	NULL
)	NULL
,	NULL
and	NULL
vitamin	NULL
D	NULL
;	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
.	NULL

They	NULL
are	NULL
members	NULL
of	NULL
the	NULL
steroid	NULL
receptor	NULL
superfamily	NULL
and	NULL
act	NULL
as	NULL
ligand-inducible	NULL
transcription	NULL
factors	NULL
by	NULL
binding	NULL
to	NULL
their	NULL
cognate	NULL
responsive	NULL
DNA	NULL
elements	NULL
,	NULL
termed	NULL
the	NULL
RA-responsive	NULL
element	NULL
(	NULL
RARE	NULL
)	NULL
and	NULL
vitamin	NULL
D	NULL
,	NULL
-responsive	NULL
element	NULL
(	NULL
VDRE	NULL
)	NULL
.	NULL

!	NULL

*	NULL
``	NULL
2	NULL
RAR	NULL
and	NULL
VDR	NULL
heterodimerize	NULL
with	NULL
RXR	NULL
to	NULL
bind	NULL
DNA	NULL
with	NULL
high	NULL
affinity	NULL
and	NULL
effect	NULL
efficient	NULL
transcriptional	NULL
activation	NULL
of	NULL
target	NULL
genes	NULL
.	NULL

!	NULL

3	NULL
!	NULL

5	NULL
Inhibition	NULL
of	NULL
the	NULL
G1/S	NULL
transition	NULL
induces	NULL
growth	NULL
arrest	NULL
and	NULL
monocytic	NULL
differentiation	NULL
of	NULL
both	NULL
HL-60	NULL
and	NULL
U937	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
block	NULL
of	NULL
cell	NULL
cycle	NULL
progression	NULL
at	NULL
the	NULL
G1	NULL
phase	NULL
.	NULL
``	NULL

The	NULL
p21	NULL
45Â°	NULL
!	NULL

protein	NULL
is	NULL
a	NULL
cyclin-dependent	NULL
kinase	NULL
(	NULL
cdk	NULL
)	NULL
inhibitor	NULL
that	NULL
is	NULL
one	NULL
of	NULL
the	NULL
regulators	NULL
of	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
the	NULL
G1/S	NULL
transition	NULL
.	NULL

Exposure	NULL
of	NULL
HL-60	NULL
cells	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
causes	NULL
transient	NULL
overexpression	NULL
of	NULL
p21	NULL
17	NULL
Further	NULL
studies	NULL
showed	NULL
that	NULL
the	NULL
p21	NULL
4C	NULL
!	NULL

promoter	NULL
contains	NULL
a	NULL
VDRE	NULL
,	NULL
and	NULL
exposure	NULL
of	NULL
U937	NULL
myelomonoblasts	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
7	NULL
(	NULL
April	NULL
1	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
2225-2233	NULL
cells	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
p21W4	NULL
``	NULL
*~Â°	NULL
``	NULL
``	NULL
and	NULL
p27*	NULL
``	NULL
``	NULL
mRNA	NULL
and	NULL
protein	NULL
increased	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
p21	NULL
and	NULL
p27	NULL
``	NULL
transcripts	NULL
were	NULL
induced	NULL
after	NULL
6	NULL
hours	NULL
'	NULL
exposure	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
then	NULL
decreased	NULL
to	NULL
basal	NULL
levels	NULL
over	NULL
48	NULL
hours	NULL
.	NULL

Western	NULL
blot	NULL
experiments	NULL
showed	NULL
that	NULL
p21	NULL
``	NULL
4	NULL
``	NULL
``	NULL
``	NULL
``	NULL
protein	NULL
levels	NULL
increased	NULL
and	NULL
became	NULL
detectable	NULL
after	NULL
12	NULL
hours	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
>	NULL
D	NULL
;	NULL
treatment	NULL
and	NULL
induction	NULL
of	NULL
p27*	NULL
``	NULL
``	NULL
protein	NULL
was	NULL
much	NULL
more	NULL
gradual	NULL
and	NULL
sustained	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
RA	NULL
markedly	NULL
enhanced	NULL
the	NULL
levels	NULL
of	NULL
p27*	NULL
``	NULL
``	NULL
transcript	NULL
and	NULL
protein	NULL
as	NULL
compared	NULL
with	NULL
levels	NULL
induced	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
Â»	NULL
D	NULL
;	NULL
alone	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
exogenous	NULL
p27	NULL
**	NULL
``	NULL
expression	NULL
can	NULL
enhance	NULL
the	NULL
level	NULL
of	NULL
CD11b	NULL
antigen	NULL
in	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
RA	NULL
alone	NULL
can	NULL
induce	NULL
G1	NULL
arrest	NULL
of	NULL
UF-1	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
it	NULL
did	NULL
not	NULL
result	NULL
in	NULL
an	NULL
increase	NULL
of	NULL
p21	NULL
and	NULL
p27*	NULL
``	NULL
``	NULL
transcript	NULL
and	NULL
protein	NULL
expression	NULL
in	NULL
RA-resistant	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induces	NULL
increased	NULL
expression	NULL
of	NULL
cdk	NULL
inhibitors	NULL
,	NULL
which	NULL
mediates	NULL
a	NULL
G1	NULL
arrest	NULL
,	NULL
and	NULL
this	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
differentiation	NULL
of	NULL
RA-resistant	NULL
UF-1	NULL
cells	NULL
toward	NULL
mature	NULL
granulocytes	NULL
.	NULL

Â©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

results	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
probably	NULL
through	NULL
a	NULL
ligand/VDR/VDRE	NULL
interaction	NULL
.	NULL

'*	NULL
Another	NULL
report	NULL
has	NULL
suggested	NULL
that	NULL
p27	NULL
``	NULL
protein	NULL
is	NULL
also	NULL
a	NULL
strong	NULL
candidate	NULL
as	NULL
a	NULL
cell	NULL
cycle	NULL
regulator	NULL
that	NULL
blocks	NULL
the	NULL
entry	NULL
into	NULL
S	NULL
phase	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
.	NULL
``	NULL

Several	NULL
clinical	NULL
studies	NULL
have	NULL
recently	NULL
reported	NULL
that	NULL
all-trans	NULL
RA	NULL
achieved	NULL
a	NULL
complete	NULL
remission	NULL
in	NULL
most	NULL
patients	NULL
with	NULL
APL	NULL
via	NULL
an	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
leukemic	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Nevertheless	NULL
,	NULL
most	NULL
patients	NULL
who	NULL
received	NULL
continuous	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
and	NULL
Clinical	NULL
Laboratories	NULL
,	NULL
Keio	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Tokyo	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Cellular	NULL
Oncology/Microbiology	NULL
,	NULL
Faculty	NULL
of	NULL
Dentistry	NULL
,	NULL
Tokyo	NULL
Medical	NULL
and	NULL
Dental	NULL
University	NULL
,	NULL
Tokyo	NULL
;	NULL
the	NULL
Division	NULL
of	NULL
Oral	NULL
Science	NULL
,	NULL
The	NULL
National	NULL
Institute	NULL
of	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
California-Los	NULL
Angeles	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
December	NULL
3	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
November	NULL
19	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
,	NULL
the	NULL
National	NULL
Grant-in-Aid	NULL
for	NULL
the	NULL
Establishment	NULL
of	NULL
a	NULL
High-Tech	NULL
Research	NULL
Center	NULL
in	NULL
a	NULL
Private	NULL
University	NULL
and	NULL
the	NULL
Keio	NULL
University	NULL
Special	NULL
Grants	NULL
as	NULL
well	NULL
as	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
US	NULL
Army	NULL
,	NULL
and	NULL
Parker	NULL
Hughes	NULL
Fund	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Masahiro	NULL
Kizaki	NULL
,	NULL
MD	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Keio	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
35	NULL
Shinanomachi	NULL
,	NULL
Shinjuku-ku	NULL
,	NULL
Tokyo	NULL
160-8582	NULL
,	NULL
Japan	NULL
;	NULL
e-mail	NULL
:	NULL
makizaki	NULL
@	NULL
me.med.keio.ac.jp	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/99/9307-0005	NULL
$	NULL
3.00/0	NULL
2225	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2226	NULL
treatment	NULL
with	NULL
RA	NULL
relapsed	NULL
and	NULL
developed	NULL
RA-resistant	NULL
dis-ease	NULL
.	NULL
``	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
and	NULL
strategies	NULL
to	NULL
overcome	NULL
RA	NULL
resistance	NULL
by	NULL
APL	NULL
cells	NULL
are	NULL
still	NULL
unclear	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
established	NULL
a	NULL
novel	NULL
APL	NULL
cell	NULL
line	NULL
(	NULL
UF-1	NULL
)	NULL
with	NULL
RA-resistant	NULL
features	NULL
that	NULL
can	NULL
be	NULL
used	NULL
as	NULL
a	NULL
model	NULL
for	NULL
studies	NULL
on	NULL
RA	NULL
resistance	NULL
in	NULL
APL	NULL
cells	NULL
.	NULL

?	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
report	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
can	NULL
overcome	NULL
RA	NULL
resistance	NULL
in	NULL
this	NULL
model	NULL
system	NULL
of	NULL
APL	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
chemicals	NULL
.	NULL

-	NULL
The	NULL
RA-resistant	NULL
UF-1	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
was	NULL
established	NULL
in	NULL
our	NULL
laboratory	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
APL	NULL
in	NULL
relapse	NULL
who	NULL
had	NULL
received	NULL
all-trans	NULL
RA	NULL
.	NULL
``	NULL

HL-60	NULL
and	NULL
NB4	NULL
promyelocytic	NULL
cells	NULL
are	NULL
RA-responsive	NULL
leukemic	NULL
cells	NULL
(	NULL
the	NULL
latter	NULL
being	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
M.	NULL
Lanotte	NULL
,	NULL
Hopital	NULL
St	NULL
Louis	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL
``	NULL

The	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
GIBCO-BRL	NULL
;	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
[	NULL
FCS	NULL
]	NULL
Hyclone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
100	NULL
U/mL	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
mg/mL	NULL
streptomycin	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

All-trans	NULL
RA	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Chugai	NULL
Pharmaceutical	NULL
Co	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

They	NULL
were	NULL
dissolved	NULL
in	NULL
100	NULL
%	NULL
ethanol	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
1	NULL
mmol/L	NULL
,	NULL
stored	NULL
at	NULL
-20Â°C	NULL
,	NULL
and	NULL
protected	NULL
from	NULL
light	NULL
.	NULL

The	NULL
morphology	NULL
and	NULL
cytochemistry	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
evaluated	NULL
from	NULL
cytospin	NULL
slide	NULL
preparations	NULL
with	NULL
Giemsa	NULL
and	NULL
naphthol	NULL
AS-D	NULL
chloroacetate	NULL
esterase	NULL
staining	NULL
.	NULL

Assays	NULL
for	NULL
cellular	NULL
proliferation	NULL
.	NULL

Cellular	NULL
proliferation	NULL
was	NULL
measured	NULL
by	NULL
cell	NULL
viability	NULL
and	NULL
a	NULL
nonradioactive	NULL
cell	NULL
proliferation	NULL
assay	NULL
system	NULL
(	NULL
MTT	NULL
assay	NULL
;	NULL
Bochringer-Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
2	NULL
X	NULL
103	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
chemicals	NULL
for	NULL
4	NULL
days	NULL
in	NULL
96-well	NULL
plates	NULL
(	NULL
Flow	NULL
Laboratories	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Ten	NULL
microliters	NULL
of	NULL
MTT	NULL
(	NULL
3-	NULL
(	NULL
4,5-dimethylthiazole-2-y1	NULL
)	NULL
-2,5-diphenyltetrazolium	NULL
bromide	NULL
,	NULL
5	NULL
ug/mL	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
after	NULL
4	NULL
hours	NULL
of	NULL
incubation	NULL
by	NULL
adding	NULL
100	NULL
uL	NULL
0.04N	NULL
HCl	NULL
in	NULL
isopropanol	NULL
,	NULL
and	NULL
absorbance	NULL
at	NULL
570	NULL
nm	NULL
was	NULL
determined	NULL
.	NULL

Control	NULL
Â»	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
2Ds3	NULL
MUTO	NULL
ET	NULL
AL	NULL
Flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
cellular	NULL
differentiation	NULL
,	NULL
expression	NULL
of	NULL
cell-surface	NULL
antigens	NULL
was	NULL
determined	NULL
by	NULL
an	NULL
immunofluorescence	NULL
staining	NULL
technique	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
human	NULL
AB	NULL
serum	NULL
(	NULL
Sigma	NULL
)	NULL
to	NULL
block	NULL
Fc	NULL
receptors	NULL
and	NULL
then	NULL
stained	NULL
using	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
mouse	NULL
anti-human	NULL
CD14	NULL
and	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
mouse	NULL
anti-human	NULL
CD11b	NULL
antibodies	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Control	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
nonbinding	NULL
control	NULL
mouse	NULL
IgG	NULL
;	NULL
and	NULL
IgG	NULL
Â»	NULL
,	NULL
isotype	NULL
antibodies	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
by	NULL
a	NULL
Cytron	NULL
Absolute	NULL
Flow	NULL
Cytometer	NULL
(	NULL
Ortho	NULL
Diagnostic	NULL
Systems	NULL
,	NULL
Raritan	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
.	NULL

-	NULL
Cells	NULL
(	NULL
1	NULL
X	NULL
10Â°	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
hypotonic	NULL
solution	NULL
(	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
mmol/L	NULL
Tris	NULL
hydrochloride	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
3.4	NULL
mmol/L	NULL
sodium	NULL
citrate	NULL
,	NULL
and	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
and	NULL
stained	NULL
with	NULL
5	NULL
ug/mL	NULL
propidium	NULL
iodide	NULL
.	NULL

Analysis	NULL
was	NULL
performed	NULL
immediately	NULL
after	NULL
staining	NULL
using	NULL
the	NULL
CELLEIT	NULL
program	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blotting	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
the	NULL
Isogen	NULL
kit	NULL
(	NULL
Nippon	NULL
Gene	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instruction	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
15	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
was	NULL
electropho-resed	NULL
on	NULL
formaldehyde-agarose	NULL
gels	NULL
(	NULL
GIBCO-BRL	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
Hybond	NULL
N*	NULL
;	NULL
Amersham	NULL
Japan	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
hybridized	NULL
with	NULL
P-labeled	NULL
probe	NULL
for	NULL
24	NULL
hours	NULL
at	NULL
42Â°C	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
2X	NULL
SSC	NULL
(	NULL
1X	NULL
SSC	NULL
is	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
plus	NULL
15	NULL
mmol/L	NULL
sodium	NULL
citrate	NULL
,	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
5X	NULL
Denhardt	NULL
solution	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
,	NULL
and	NULL
100	NULL
ug/mL	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
to	NULL
a	NULL
stringency	NULL
of	NULL
0.1X	NULL
SSC	NULL
at	NULL
65Â°C	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Autoradiograms	NULL
were	NULL
exposed	NULL
for	NULL
24	NULL
hours	NULL
to	NULL
3	NULL
days	NULL
.	NULL

Densitometry	NULL
was	NULL
performed	NULL
for	NULL
signal	NULL
intensity	NULL
on	NULL
autoradiograms	NULL
of	NULL
Northern	NULL
blots	NULL
using	NULL
a	NULL
digital	NULL
densitometer	NULL
.	NULL

DNA	NULL
probes	NULL
.	NULL

The	NULL
plasmid	NULL
containing	NULL
human	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
``	NULL
cDNA	NULL
(	NULL
Notl-NofI	NULL
;	NULL
2.1	NULL
kb	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
B.	NULL
Vogelstein	NULL
(	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
``	NULL
and	NULL
the	NULL
human	NULL
p27**	NULL
``	NULL
``	NULL
cDNA	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
pBluescript	NULL
II	NULL
SK	NULL
plasmid	NULL
(	NULL
EcoRI-EcoRI	NULL
,	NULL
1.5	NULL
kb	NULL
;	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
J.	NULL
MassaguÃ©	NULL
,	NULL
Memorial-Sloan	NULL
Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
Fig	NULL
1	NULL
.	NULL

Morphologic	NULL
and	NULL
cytochemical	NULL
changes	NULL
in	NULL
RA-resistant	NULL
APL	NULL
cells	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
.	NULL

UF-1	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
either	NULL
10-	NULL
``	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
or	NULL
culture	NULL
media	NULL
alone	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
for	NULL
4	NULL
days	NULL
,	NULL
and	NULL
cytospin	NULL
slides	NULL
were	NULL
prepared	NULL
and	NULL
stained	NULL
with	NULL
either	NULL
Giemsa	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
naphthol	NULL
AS-D	NULL
chloroacetate	NULL
esterase	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Original	NULL
magnification	NULL
x1,000	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

DIFFERENTIATION	NULL
AND	NULL
edk	NULL
INHIBITORS	NULL
2227	NULL
Fig	NULL
2	NULL
.	NULL

Dose-	NULL
and	NULL
time-dependent	NULL
effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
and/	NULL
or	NULL
all-trans	NULL
RA	NULL
on	NULL
cellular	NULL
proliferation	NULL
of	NULL
UF-1	NULL
cells	NULL
.	NULL

RA-resistant	NULL
UF-1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
96-well	NULL
plates	NULL
with	NULL
various	NULL
concentrations	NULL
(	NULL
101Â°	NULL
to	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
for	NULL
4	NULL
days	NULL
(	NULL
A	NULL
)	NULL
or	NULL
for	NULL
different	NULL
times	NULL
(	NULL
0-96	NULL
hours	NULL
)	NULL
with	NULL
the	NULL
indicated	NULL
compounds	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
then	NULL
MTT	NULL
incorporation	NULL
was	NULL
20	NULL
measured	NULL
.	NULL

Absorbance	NULL
at	NULL
570	NULL
nm	NULL
(	NULL
OD	NULL
;	NULL
,	NULL
,	NULL
)	NULL
was	NULL
re-	NULL
corded	NULL
using	NULL
an	NULL
enzyme-linked	NULL
immunosorbent	NULL
as	NULL
ODsro	NULL
(	NULL
%	NULL
of	NULL
control	NULL
}	NULL
All-trans	NULL
RA1O	NULL
'M	NULL
All-trans	NULL
RA	NULL
100	NULL
1,25	NULL
1,25	NULL
(	NULL
OHJaDet	NULL
0M	NULL
60-7	NULL
:	NULL
All-trans	NULL
RA10M	NULL
All-trans	NULL
RA10	NULL
M	NULL
_	NULL
M	NULL
+1,25	NULL
(	NULL
OH	NULL
)	NULL
aDa	NULL
40	NULL
+1,25	NULL
(	NULL
OH	NULL
}	NULL
eDs10	NULL
``	NULL
``	NULL
M	NULL
20	NULL
say	NULL
plate	NULL
reader	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
experiments	NULL
;	NULL
the	NULL
SD	NULL
was	NULL
within	NULL
10	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

0	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
.	NULL
``	NULL

These	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-	NULL
>	NULL
2P	NULL
]	NULL
dCTP	NULL
using	NULL
the	NULL
rediprime	NULL
DNA	NULL
labeling	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
activity	NULL
was	NULL
approximately	NULL
2	NULL
X	NULL
10Â°	NULL
cpm/ug	NULL
DNA	NULL
.	NULL

Western	NULL
blotting	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
at	NULL
1,200	NULL
rpm	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
then	NULL
the	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mmol/L	NULL
,	NULL
40	NULL
mmol/L	NULL
Tris	NULL
hydrochloride	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
and	NULL
150	NULL
mmol/L	NULL
NaC	NULL
)	NULL
)	NULL
at	NULL
4Â°C	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
system	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
10	NULL
ug	NULL
protein	NULL
per	NULL
lane	NULL
)	NULL
were	NULL
fractionated	NULL
in	NULL
12.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
before	NULL
transfer	NULL
to	NULL
the	NULL
membrane	NULL
(	NULL
Immobilon-P	NULL
membranes	NULL
;	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
by	NULL
standard	NULL
proto-col	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
blocked	NULL
overnight	NULL
with	NULL
5	NULL
%	NULL
defatted	NULL
milk	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
anti-p21	NULL
A	NULL
``	NULL
/CIP	NULL
!	NULL

_p27KIP1	NULL
,	NULL
-p15	NULL
``	NULL
**2	NULL
,	NULL
and	NULL
-p16	NULL
``	NULL
**A	NULL
antibodies	NULL
(	NULL
Calbiochem	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
were	NULL
used	NULL
at	NULL
1:1,000	NULL
dilution	NULL
in	NULL
5	NULL
%	NULL
defatted	NULL
milk	NULL
in	NULL
PBS	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
25Â°C	NULL
.	NULL

Subsequently	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
anti-rabbit	NULL
Ig	NULL
conjugated	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
1:3,000	NULL
;	NULL
Amersham	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
25Â°C	NULL
.	NULL

All	NULL
steps	NULL
were	NULL
followed	NULL
by	NULL
three	NULL
washes	NULL
for	NULL
5	NULL
minutes	NULL
in	NULL
PBS	NULL
,	NULL
1	NULL
%	NULL
defatted	NULL
milk	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

Antibody	NULL
binding	NULL
was	NULL
detected	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
kit	NULL
for	NULL
Western	NULL
blotting	NULL
detection	NULL
with	NULL
hyper-ECL	NULL
film	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
stained	NULL
with	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
and	NULL
confirmed	NULL
to	NULL
contain	NULL
a	NULL
similar	NULL
amount	NULL
of	NULL
protein	NULL
extract	NULL
on	NULL
each	NULL
lane	NULL
.	NULL

Plasmid	NULL
and	NULL
transfection	NULL
.	NULL

The	NULL
full-length	NULL
human	NULL
p27	NULL
``	NULL
cDNA	NULL
plasmid	NULL
(	NULL
pBluescript	NULL
II	NULL
SK-hp27	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
in	NULL
a	NULL
polymerase	NULL
chain	NULL
reaction	NULL
to	NULL
amplify	NULL
the	NULL
human	NULL
p27	NULL
``	NULL
cDNA	NULL
fragment	NULL
(	NULL
codons	NULL
2	NULL
to	NULL
199	NULL
)	NULL
that	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Bg/I	NULL
and	NULL
BamHI	NULL
sites	NULL
of	NULL
the	NULL
pBGFP-C1	NULL
expression	NULL
vector	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
IE	NULL
promoter	NULL
and	NULL
green	NULL
fluorescent	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
resultant	NULL
plasmid	NULL
was	NULL
designated	NULL
pEGFP-hKIP1	NULL
.	NULL

The	NULL
pEGFP-neo	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
Table	NULL
1	NULL
.	NULL

Cell	NULL
Cycle	NULL
Analysis	NULL
of	NULL
UF-1	NULL
Cells	NULL
%	NULL
Fluorescence	NULL
at	NULL
Cell	NULL
Cycle	NULL
Phase	NULL
:	NULL
Treatment	NULL
Go/G1	NULL
S	NULL
GM	NULL
Control	NULL
80.2	NULL
13.8	NULL
6.0	NULL
All-frans	NULL
RA	NULL
91.9	NULL
6.7	NULL
1.5	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
Â»	NULL
D	NULL
;	NULL
93.3	NULL
5.0	NULL
1.7	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
+	NULL
all-frans	NULL
RA	NULL
98.4	NULL
0.5	NULL
1.1	NULL
UF-1	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
either	NULL
10~	NULL
``	NULL
mol/L	NULL
all-trans	NULL
RA	NULL
,	NULL
10-	NULL
``	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
for	NULL
48	NULL
hours	NULL
.	NULL

DNA	NULL
was	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
,	NULL
and	NULL
analysis	NULL
was	NULL
immediately	NULL
performed	NULL
using	NULL
the	NULL
CELLFIT	NULL
program	NULL
.	NULL

10	NULL
10Â°	NULL
10Â°	NULL
107	NULL
concentration	NULL
(	NULL
mol/L	NULL
)	NULL
0	NULL
T	NULL
T	NULL
I	NULL
T	NULL
T	NULL
T	NULL
T	NULL
I	NULL
0	NULL
12	NULL
24	NULL
36	NULL
48	NULL
60	NULL
72	NULL
84	NULL
96	NULL
time	NULL
{	NULL
(	NULL
hours	NULL
)	NULL
plasmid	NULL
.	NULL

Exponentially	NULL
growing	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10	NULL
``	NULL
/mL	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
plasmids	NULL
by	NULL
electroporation	NULL
using	NULL
a	NULL
Gene	NULL
Pulser	NULL
II	NULL
(	NULL
Bio-Rad	NULL
)	NULL
set	NULL
at	NULL
240	NULL
V	NULL
,	NULL
1,000	NULL
uF	NULL
.	NULL

A	NULL
pulse	NULL
was	NULL
delivered	NULL
to	NULL
300	NULL
uL	NULL
cell	NULL
suspension	NULL
and	NULL
30	NULL
ug	NULL
plasmid	NULL
DNA	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
of	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
PE-conjugated	NULL
mouse	NULL
anti-human	NULL
CD11b	NULL
antibody	NULL
(	NULL
Becton	NULL
Dick-inson	NULL
)	NULL
and	NULL
analyzed	NULL
for	NULL
CD11b	NULL
positive	NULL
cells	NULL
in	NULL
the	NULL
GFP-positive	NULL
fraction	NULL
by	NULL
two-color	NULL
flow	NULL
cytometry	NULL
.	NULL

RESULTS	NULL
Morphologic	NULL
changes	NULL
induced	NULL
in	NULL
RA-resistant	NULL
APL	NULL
cells	NULL
(	NULL
UF-1	NULL
)	NULL
cultured	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

UPF-1	NULL
cells	NULL
in	NULL
control	NULL
cultures	NULL
showed	NULL
large	NULL
round	NULL
nuclei	NULL
and	NULL
numerous	NULL
granules	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
as	NULL
found	NULL
with	NULL
hypergranulocytic	NULL
promyelocytes	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Incubation	NULL
with	NULL
10~	NULL
``	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
4	NULL
days	NULL
resulted	NULL
in	NULL
differentiation	NULL
of	NULL
UF-1	NULL
cells	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
nuclear	NULL
maturation	NULL
and	NULL
lobulation	NULL
,	NULL
and	NULL
a	NULL
diminished	NULL
number	NULL
of	NULL
granules	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Naphthol	NULL
AS-D	NULL
chloroacetate	NULL
esterase	NULL
was	NULL
positive	NULL
for	NULL
both	NULL
control	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
Ds-treated	NULL
UE-1	NULL
cells	NULL
(	NULL
Fig	NULL
1C	NULL
and	NULL
D	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
these	NULL
cells	NULL
being	NULL
of	NULL
the	NULL
granulocytic	NULL
lineage	NULL
.	NULL

Effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
cellular	NULL
proliferation	NULL
of	NULL
UF-1	NULL
cells	NULL
.	NULL

UF-1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
10-	NULL
'	NULL
to	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
with	NULL
or	NULL
without	NULL
all-trans	NULL
RA	NULL
(	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
for	NULL
4	NULL
days	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
agents	NULL
for	NULL
different	NULL
times	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
,	NULL
``	NULL
all-trans	NULL
RA	NULL
alone	NULL
did	NULL
not	NULL
effect	NULL
growth	NULL
of	NULL
UF-1	NULL
cells	NULL
,	NULL
as	NULL
reflected	NULL
by	NULL
a	NULL
lack	NULL
of	NULL
change	NULL
in	NULL
their	NULL
absorbance	NULL
in	NULL
the	NULL
MTT	NULL
assay	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
inhibited	NULL
the	NULL
cellular	NULL
proliferation	NULL
and	NULL
decreased	NULL
the	NULL
number	NULL
of	NULL
viable	NULL
cells	NULL
in	NULL
a	NULL
dose	NULL
(	NULL
10-	NULL
'	NULL
``	NULL
to	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
-	NULL
and	NULL
time	NULL
(	NULL
0	NULL
to	NULL
96	NULL
hours	NULL
)	NULL
-dependent	NULL
manner	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
10-	NULL
``	NULL
mol/L	NULL
all-trans	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
markedly	NULL
inhibited	NULL
cell	NULL
growth	NULL
in	NULL
a	NULL
dose-	NULL
and	NULL
time-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
2A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
and	NULL
all-trans	NULL
RA	NULL
on	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
10~	NULL
'	NULL
mol/L	NULL
all-trans	NULL
RA	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
for	NULL
48	NULL
hours	NULL
and	NULL
analyzed	NULL
for	NULL
cell	NULL
cycle	NULL
distribution	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Cultivation	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
48	NULL
hours	NULL
increased	NULL
the	NULL
population	NULL
of	NULL
cells	NULL
in	NULL
G1	NULL
phase	NULL
from	NULL
80.2	NULL
%	NULL
to	NULL
93.3	NULL
%	NULL
with	NULL
a	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2228	NULL
reduction	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
from	NULL
13.8	NULL
%	NULL
to	NULL
5.0	NULL
%	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
cellular	NULL
proliferation	NULL
assay	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
all-trans	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
significantly	NULL
increased	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
G1	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
98.4	NULL
%	NULL
)	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
(	NULL
80.2	NULL
%	NULL
)	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
decrease	NULL
in	NULL
the	NULL
S	NULL
phase	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

These	NULL
increased	NULL
populations	NULL
of	NULL
G1	NULL
phase	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-treated	NULL
cells	NULL
represent	NULL
G1-arrested	NULL
cells	NULL
.	NULL

Functional	NULL
evidence	NULL
for	NULL
differentiation	NULL
of	NULL
UF-1	NULL
cells	NULL
to	NULL
granulocytes	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D3	NULL
.	NULL

-	NULL
Induction	NULL
of	NULL
the	NULL
differentiation	NULL
of	NULL
UF-1	NULL
cells	NULL
to	NULL
granulocytes	NULL
by	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
CD11b	NULL
and	NULL
CD14	NULL
antigens	NULL
(	NULL
Figs	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

All-trans	NULL
RA	NULL
(	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
expression	NULL
of	NULL
CD11b	NULL
and	NULL
CD14	NULL
antigens	NULL
by	NULL
fluorescent-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
107Â°	NULL
to	NULL
10~	NULL
``	NULL
mol/L	NULL
)	NULL
induced	NULL
CD11b	NULL
positive	NULL
cells	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
from	NULL
1	NULL
%	NULL
to	NULL
66	NULL
%	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
plus	NULL
all-trans	NULL
RA	NULL
(	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
greatly	NULL
enhanced	NULL
the	NULL
expression	NULL
of	NULL
CD11b	NULL
antigen	NULL
as	NULL
compared	NULL
with	NULL
either	NULL
agent	NULL
alone	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
CD14	NULL
antigen	NULL
was	NULL
unchanged	NULL
after	NULL
exposure	NULL
to	NULL
either	NULL
Control	NULL
CD11b	NULL
CD11b	NULL
10Â°	NULL
10Â°	NULL
10	NULL
'	NULL
...	NULL
MUTO	NULL
ET	NULL
AL	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
alone	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
Figs	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
morphologic	NULL
and	NULL
cytochemical	NULL
studies	NULL
,	NULL
suggesting	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induces	NULL
differentiation	NULL
of	NULL
UF-1	NULL
cells	NULL
down	NULL
the	NULL
granulocytic	NULL
pathway	NULL
and	NULL
RA	NULL
can	NULL
enhance	NULL
this	NULL
effect	NULL
.	NULL

Expression	NULL
of	NULL
p2IY*	NULL
``	NULL
C*	NULL
``	NULL
'	NULL
and	NULL
p27	NULL
mRNA	NULL
in	NULL
HL-60	NULL
,	NULL
NB4	NULL
,	NULL
and	NULL
UF-1	NULL
cells	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induced	NULL
the	NULL
differentiation	NULL
of	NULL
UE-1	NULL
cells	NULL
in	NULL
association	NULL
with	NULL
a	NULL
block	NULL
of	NULL
cell	NULL
cycle	NULL
progression	NULL
at	NULL
the	NULL
G1	NULL
phase	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
address	NULL
the	NULL
mechanisms	NULL
of	NULL
action	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
RA-resistant	NULL
APL	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
expression	NULL
of	NULL
edk	NULL
inhibitors	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
can	NULL
induce	NULL
HL-60	NULL
cells	NULL
to	NULL
differentiate	NULL
into	NULL
monocyte/macrophage-like	NULL
cells	NULL
.	NULL

Forty-eight	NULL
hours	NULL
'	NULL
incubation	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
10~	NULL
``	NULL
mol/L	NULL
)	NULL
was	NULL
sufficient	NULL
to	NULL
commit	NULL
HL-60	NULL
cells	NULL
to	NULL
differentiate	NULL
along	NULL
the	NULL
monocyte/macrophage	NULL
pathway	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
hours	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10-	NULL
``	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
and	NULL
then	NULL
the	NULL
expression	NULL
of	NULL
p21	NULL
4	NULL
``	NULL
!	NULL

and	NULL
p27**	NULL
``	NULL
transcripts	NULL
was	NULL
examined	NULL
by	NULL
Northern	NULL
blotting	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
p2174	NULL
``	NULL
``	NULL
<	NULL
!	NULL

mRNA	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
control	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
accumulation	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
C	NULL
``	NULL
'	NULL
mRNA	NULL
in	NULL
All-trans	NULL
RA1O~M	NULL
o	NULL
101	NULL
10Â°	NULL
10Â°	NULL
cor4	NULL
[	NULL
~	NULL
--	NULL
--	NULL
--	NULL
-	NULL
1	NULL
,	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
2Ds	NULL
CD11b	NULL
10Â°M	NULL
CDiib	NULL
10Â°M	NULL
CD11b	NULL
107M	NULL
10Â°	NULL
10Â°	NULL
10	NULL
``	NULL
}	NULL
...	NULL
.	NULL

10Â°	NULL
_	NULL
sel	NULL
ad	NULL
10Â°	NULL
10	NULL
-	NULL
if	NULL
-	NULL
id	NULL
19g	NULL
~~	NULL
19	NULL
``	NULL
19	NULL
-	NULL
io	NULL
19	NULL
r9	NULL
$	NULL
10	NULL
-	NULL
10	NULL
``	NULL
co14	NULL
con4	NULL
con4	NULL
All-trans	NULL
RA10	NULL
``	NULL
M	NULL
[	NULL
--	NULL
-	NULL
1	NULL
,	NULL
25	NULL
(	NULL
BH	NULL
)	NULL
2D3	NULL
_|	NULL
Fig	NULL
3	NULL
.	NULL

Expression	NULL
of	NULL
CD11b	NULL
and	NULL
CD14	NULL
antigens	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

UF-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
10-7	NULL
mol/L	NULL
all-trans	NULL
RA	NULL
,	NULL
various	NULL
concentrations	NULL
(	NULL
10-Â°	NULL
to	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
,	NULL
or	NULL
combinations	NULL
of	NULL
both	NULL
for	NULL
4	NULL
days	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
human	NULL
AB	NULL
serum	NULL
to	NULL
block	NULL
Fe	NULL
receptors	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
direct	NULL
immunofluorescence	NULL
using	NULL
FITC-conjugated	NULL
mouse	NULL
anti-human	NULL
CD14	NULL
and	NULL
PE-conjugated	NULL
mouse	NULL
anti-human	NULL
CD11b	NULL
antibodies	NULL
.	NULL

Control	NULL
conb	NULL
10Â°M	NULL
coitb	NULL
10Â°M	NULL
coitb	NULL
10	NULL
``	NULL
M	NULL
10	NULL
10Â°	NULL
10Â°	NULL
10	NULL
.	NULL

10	NULL
}	NULL
.	NULL

10Â°10	NULL
``	NULL
10Â°	NULL
10	NULL
10Â°	NULL
â	NULL
010Â°	NULL
10	NULL
10	NULL
``	NULL
10Â°	NULL
co14	NULL
cor4	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
nonbinding	NULL
control	NULL
mouse	NULL
IgG	NULL
,	NULL
and	NULL
IgG	NULL
,	NULL
,	NULL
isotype	NULL
antibodies	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

DIFFERENTIATION	NULL
AND	NULL
edk	NULL
INHIBITORS	NULL
Control	NULL
p	NULL
[	NULL
J	NULL
)	NULL
CDilb	NULL
All-frans	NULL
RA	NULL
10	NULL
Â°M	NULL
&	NULL
I	NULL
co14	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
:	NULL
D:10Â°M	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
D:10Â°M	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
:	NULL
D:10Â°M	NULL
|	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
:	NULL
D:10Â°M	NULL
+All-trans	NULL
RA	NULL
10Â°M	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
:	NULL
D:10Â°M	NULL
+All-trans	NULL
RA	NULL
10Â°M	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
:	NULL
D:10Â°M	NULL
|	NULL
+All-frans	NULL
RA	NULL
10Â°M	NULL
0.0	NULL
25.0	NULL
50.0	NULL
75.0	NULL
100.0	NULL
%	NULL
of	NULL
positive	NULL
cells	NULL
Fig	NULL
4	NULL
.	NULL

Graphic	NULL
representation	NULL
of	NULL
the	NULL
FACS	NULL
analysis	NULL
of	NULL
CD11b	NULL
and	NULL
CD14	NULL
antigens	NULL
shown	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

Results	NULL
show	NULL
the	NULL
differentiation-inducing	NULL
activities	NULL
of	NULL
all-frans	NULL
RA	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
and	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
chemicals	NULL
.	NULL

creased	NULL
after	NULL
the	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
p21WAF/CP	NULL
!	NULL

was	NULL
associated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
to	NULL
monocytes/	NULL
macrophages	NULL
.	NULL

NB4	NULL
cells	NULL
are	NULL
genetically	NULL
different	NULL
from	NULL
HL-60	NULL
cells	NULL
in	NULL
that	NULL
they	NULL
possess	NULL
a	NULL
reciprocal	NULL
chromosomal	NULL
translation	NULL
,	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
,	NULL
which	NULL
is	NULL
characteristic	NULL
of	NULL
APL	NULL
cells	NULL
.	NULL
``	NULL

NB4	NULL
cells	NULL
respond	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
differently	NULL
from	NULL
HL-60	NULL
cells	NULL
.	NULL

Recent	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
alone	NULL
failed	NULL
to	NULL
induce	NULL
the	NULL
differentiation	NULL
of	NULL
NB4	NULL
cells	NULL
to	NULL
In	NULL
NB4	NULL
cells	NULL
,	NULL
p21	NULL
%	NULL
A	NULL
``	NULL
``	NULL
C	NULL
``	NULL
!	NULL

mRNA	NULL
was	NULL
not	NULL
detectable	NULL
constitu-tively	NULL
,	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
did	NULL
not	NULL
enhance	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
transcripts	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
p21	NULL
and	NULL
p27	NULL
``	NULL
!	NULL

transcripts	NULL
was	NULL
observed	NULL
in	NULL
RA	NULL
-resistant	NULL
UF-1	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
and	NULL
p27	NULL
``	NULL
transcripts	NULL
were	NULL
not	NULL
changed	NULL
after	NULL
48	NULL
hours	NULL
'	NULL
exposure	NULL
to	NULL
all-trans	NULL
RA	NULL
(	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
but	NULL
were	NULL
slightly	NULL
increased	NULL
after	NULL
48	NULL
hours	NULL
'	NULL
exposure	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
and	NULL
p27	NULL
``	NULL
``	NULL
*	NULL
``	NULL
'	NULL
induction	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
3	NULL
.	NULL

-	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-induced	NULL
expression	NULL
of	NULL
edk	NULL
inhibitor	NULL
p21WAF/CIP	NULL
!	NULL

was	NULL
examined	NULL
more	NULL
closely	NULL
by	NULL
comparing	NULL
A	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
2Ds	NULL
Fig	NULL
5	NULL
.	NULL

Expression	NULL
of	NULL
p21*	NULL
``	NULL
``	NULL
*	NULL
mRNA	NULL
in	NULL
HL-60	NULL
and	NULL
NB4	NULL
cells	NULL
,	NULL
and	NULL
p21	NULL
and	NULL
p27*	NULL
``	NULL
'	NULL
transcripts	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
with	NULL
either	NULL
10-	NULL
``	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
A	NULL
)	NULL
or	NULL
10~	NULL
``	NULL
mol/L	NULL
all-frans	NULL
RA	NULL
(	NULL
B	NULL
)	NULL
for	NULL
48	NULL
hours	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
15	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
was	NULL
extracted	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
with	NULL
[	NULL
*Â°P	NULL
]	NULL
-labeled	NULL
or	NULL
p27*	NULL
``	NULL
'	NULL
cDNA	NULL
probe	NULL
.	NULL

Bottom	NULL
panel	NULL
shows	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
formaldehyde	NULL
gel	NULL
before	NULL
Northern	NULL
blotting	NULL
;	NULL
the	NULL
levels	NULL
of	NULL
28S	NULL
and	NULL
18S	NULL
ribosomal	NULL
RNA	NULL
are	NULL
comparable	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

2229	NULL
transcript	NULL
and	NULL
protein	NULL
levels	NULL
over	NULL
a	NULL
time	NULL
frame	NULL
of	NULL
0	NULL
to	NULL
72	NULL
hours	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
either	NULL
with	NULL
or	NULL
without	NULL
all-trans	NULL
RA	NULL
to	NULL
UF-1	NULL
cells	NULL
(	NULL
Figs	NULL
6	NULL
,	NULL
and	NULL
8A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
related	NULL
cdk	NULL
inhibitor	NULL
p27*	NULL
``	NULL
was	NULL
also	NULL
included	NULL
in	NULL
this	NULL
analysis	NULL
(	NULL
Figs	NULL
7	NULL
and	NULL
8A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
p21	NULL
A**	NULL
!	NULL

and	NULL
p27	NULL
``	NULL
transcripts	NULL
increased	NULL
about	NULL
twofold	NULL
after	NULL
6	NULL
hours	NULL
of	NULL
exposure	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
and	NULL
then	NULL
the	NULL
expression	NULL
decreased	NULL
toward	NULL
baseline	NULL
levels	NULL
over	NULL
the	NULL
remaining	NULL
42	NULL
hours	NULL
(	NULL
Figs	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
experiments	NULL
showed	NULL
that	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
protein	NULL
levels	NULL
became	NULL
detectable	NULL
after	NULL
6	NULL
hours	NULL
and	NULL
peaked	NULL
at	NULL
12	NULL
hours	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
10~	NULL
``	NULL
mol/L	NULL
)	NULL
treatment	NULL
.	NULL

The	NULL
level	NULL
of	NULL
p27	NULL
``	NULL
!	NULL

protein	NULL
increased	NULL
by	NULL
3	NULL
hours	NULL
and	NULL
continued	NULL
to	NULL
increase	NULL
at	NULL
72	NULL
hours	NULL
of	NULL
culture	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
10-	NULL
``	NULL
mol/L	NULL
)	NULL
(	NULL
Fig	NULL
8A	NULL
)	NULL
.	NULL

The	NULL
dissociation	NULL
between	NULL
the	NULL
early	NULL
and	NULL
transient	NULL
mRNA	NULL
induction	NULL
of	NULL
p27	NULL
``	NULL
and	NULL
the	NULL
late	NULL
and	NULL
sustained	NULL
appearance	NULL
of	NULL
the	NULL
corresponding	NULL
protein	NULL
suggests	NULL
that	NULL
posttranscriptional	NULL
regulation	NULL
is	NULL
imposed	NULL
on	NULL
this	NULL
edk	NULL
inhibitor	NULL
.	NULL

All-trans	NULL
RA	NULL
combined	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
did	NULL
not	NULL
further	NULL
enhance	NULL
the	NULL
expression	NULL
of	NULL
mRNA	NULL
and	NULL
protein	NULL
(	NULL
Figs	NULL
6	NULL
and	NULL
8B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
p27**	NULL
``	NULL
``	NULL
transcripts	NULL
and	NULL
proteins	NULL
were	NULL
strongly	NULL
induced	NULL
after	NULL
6	NULL
hours	NULL
'	NULL
exposure	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
and	NULL
all-trans	NULL
RA	NULL
compared	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
alone	NULL
(	NULL
Figs	NULL
7	NULL
and	NULL
8B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
paralleled	NULL
the	NULL
synergistic	NULL
ability	NULL
of	NULL
these	NULL
two	NULL
ligands	NULL
to	NULL
induce	NULL
the	NULL
differentiation	NULL
of	NULL
UF-1	NULL
cells	NULL
toward	NULL
granulocytes	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
the	NULL
ankyrin	NULL
family	NULL
of	NULL
edk	NULL
inhibitors	NULL
that	NULL
includes	NULL
and	NULL
p16'*44	NULL
.	NULL

However	NULL
,	NULL
these	NULL
INK4	NULL
proteins	NULL
were	NULL
not	NULL
detectable	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
following	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Forced	NULL
expression	NULL
of	NULL
p27	NULL
``	NULL
induces	NULL
cellular	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
.	NULL

-	NULL
The	NULL
results	NULL
of	NULL
our	NULL
expression	NULL
studies	NULL
suggest	NULL
an	NULL
association	NULL
of	NULL
p27*	NULL
``	NULL
``	NULL
expression	NULL
and	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
induced	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
Ds	NULL
;	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
this	NULL
associa-tion	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
GFP-p27*	NULL
``	NULL
``	NULL
``	NULL
fusion	NULL
protein-expressing	NULL
plasmid	NULL
(	NULL
pEGFP-hKIP1	NULL
)	NULL
and	NULL
a	NULL
control	NULL
plasmid	NULL
(	NULL
pEGFP-neo	NULL
)	NULL
and	NULL
transfected	NULL
them	NULL
into	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

The	NULL
slow-growing	NULL
promyelocytic	NULL
NB4	NULL
and	NULL
UF-1	NULL
cells	NULL
were	NULL
impossible	NULL
to	NULL
transfect	NULL
effectively	NULL
;	NULL
therefore	NULL
,	NULL
our	NULL
experiments	NULL
focused	NULL
on	NULL
HL-60	NULL
cells	NULL
.	NULL

This	NULL
expression	NULL
vector	NULL
contains	NULL
the	NULL
GFP	NULL
reporter	NULL
gene	NULL
,	NULL
and	NULL
thus	NULL
,	NULL
the	NULL
plasmid-introduced	NULL
cell	NULL
population	NULL
was	NULL
positive	NULL
for	NULL
green	NULL
fluorescence	NULL
.	NULL

The	NULL
cell	NULL
population	NULL
that	NULL
expressed	NULL
green	NULL
fluorescence	NULL
was	NULL
evaluated	NULL
for	NULL
differentiation	NULL
by	NULL
analysis	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
CD11b	NULL
antigen	NULL
by	NULL
two-color	NULL
flow	NULL
B	NULL
HL-60	NULL
NB4	NULL
UF-1	NULL
UF-1	NULL
Fo	NULL
ar	NULL
--	NULL
-I	NULL
ro-	NULL
-I	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
All-trans	NULL
RA	NULL
-	NULL
+	NULL
to	NULL
#	NULL
B	NULL
-02	NULL
Â©	NULL
#	NULL
-	NULL
>	NULL
2	NULL
28s	NULL
WD	NULL
Atb	NULL
-p27	NULL
28s	NULL
18s	NULL
18s	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

2230	NULL
All-trans	NULL
RA	NULL
+	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
Ds	NULL
1,25	NULL
(	NULL
OHJDs	NULL
12	NULL
24	NULL
48h	NULL
12	NULL
24	NULL
48h	NULL
aree	NULL
.	NULL

1.0	NULL
0.8	NULL
Relative	NULL
mRNA	NULL
levels	NULL
28s	NULL
18s	NULL
1.0	NULL
1.5	NULL
25	NULL
3.0	NULL
1.7	NULL
1.4	NULL
1.0	NULL
1.0	NULL
2.2	NULL
23	NULL
cytometry	NULL
.	NULL

The	NULL
transient	NULL
expression	NULL
of	NULL
in	NULL
HL-60	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
rightward	NULL
shift	NULL
of	NULL
the	NULL
fluorescence	NULL
intensity	NULL
compared	NULL
with	NULL
control	NULL
vector-transfected	NULL
cells	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
.	NULL

This	NULL
clearly	NULL
suggests	NULL
that	NULL
forced	NULL
expression	NULL
of	NULL
p27	NULL
``	NULL
can	NULL
result	NULL
in	NULL
cellular	NULL
differentiation	NULL
of	NULL
leukemic	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
To	NULL
date	NULL
,	NULL
the	NULL
mechanisms	NULL
of	NULL
RA	NULL
resistance	NULL
in	NULL
APL	NULL
cells	NULL
are	NULL
still	NULL
unclear	NULL
,	NULL
and	NULL
most	NULL
approaches	NULL
have	NULL
not	NULL
been	NULL
successful	NULL
in	NULL
overcoming	NULL
RA	NULL
resistance	NULL
in	NULL
vivo	NULL
.	NULL
``	NULL

Cell	NULL
differentiation	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
cell	NULL
cycle-dependent	NULL
manner	NULL
;	NULL
for	NULL
example	NULL
,	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
loss	NULL
of	NULL
cell	NULL
cycling	NULL
capacity	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
become	NULL
arrested	NULL
in	NULL
the	NULL
GO/G1	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

``	NULL
?	NULL

Also	NULL
,	NULL
the	NULL
principal	NULL
block	NULL
to	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
-treated	NULL
human	NULL
cells	NULL
is	NULL
known	NULL
to	NULL
occur	NULL
in	NULL
the	NULL
G1	NULL
phase	NULL
.	NULL

'*	NULL
>	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
RA-resistant	NULL
UF-1	NULL
cells	NULL
differentiated	NULL
toward	NULL
granulocytes	NULL
when	NULL
cultured	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
Ds	NULL
;	NULL
,	NULL
and	NULL
this	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
G1	NULL
arrest	NULL
of	NULL
these	NULL
cells	NULL
and	NULL
an	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
cdk	NULL
inhibitors	NULL
and	NULL
Consistent	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
p21WAF/CZ	NULL
!	NULL

and	NULL
p27	NULL
``	NULL
transcripts	NULL
in	NULL
UF-1	NULL
cells	NULL
after	NULL
a	NULL
short	NULL
exposure	NULL
to	NULL
either	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
or	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
combined	NULL
with	NULL
all-trans	NULL
RA	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
cellular	NULL
proliferation	NULL
occurred	NULL
within	NULL
6	NULL
to	NULL
12	NULL
hours	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
an	NULL
increase	NULL
of	NULL
p21	NULL
AFC	NULL
!	NULL

and	NULL
p27	NULL
``	NULL
transcripts	NULL
associates	NULL
with	NULL
cyclin-edk	NULL
complexes	NULL
during	NULL
the	NULL
first	NULL
12	NULL
hours	NULL
of	NULL
exposure	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
and	NULL
is	NULL
capable	NULL
of	NULL
inhibiting	NULL
the	NULL
kinase	NULL
activities	NULL
with	NULL
these	NULL
complexes	NULL
,	NULL
leading	NULL
to	NULL
GO/G1	NULL
arrest	NULL
and	NULL
differentiation	NULL
of	NULL
the	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
transduces	NULL
its	NULL
signal	NULL
through	NULL
the	NULL
DNA-binding	NULL
transcription	NULL
factor	NULL
,	NULL
VDR	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
ligand-inducible	NULL
effects	NULL
on	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
are	NULL
initiated	NULL
through	NULL
the	NULL
direct	NULL
For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MUTO	NULL
ET	NULL
AL	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Time	NULL
course	NULL
of	NULL
p21	NULL
``	NULL
4	NULL
``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
mRNA	NULL
induction	NULL
of	NULL
expression	NULL
by	NULL
either	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
alone	NULL
or	NULL
combined	NULL
with	NULL
RA	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
various	NULL
durations	NULL
(	NULL
0	NULL
to	NULL
48	NULL
hours	NULL
)	NULL
with	NULL
10-	NULL
``	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
left	NULL
)	NULL
or	NULL
10-	NULL
mol/L	NULL
of	NULL
both	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
right	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
p21	NULL
``	NULL
4	NULL
``	NULL
``	NULL
``	NULL
``	NULL
mRNA	NULL
was	NULL
performed	NULL
by	NULL
blotting	NULL
total	NULL
RNA	NULL
(	NULL
15	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
.	NULL

Equal	NULL
loading	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
confirmed	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
formaldehyde	NULL
gel	NULL
;	NULL
thus	NULL
,	NULL
the	NULL
densitometric	NULL
reading	NULL
for	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
p21W4*	NULL
``	NULL
@	NULL
``	NULL
``	NULL
transcript	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
untreated	NULL
cells	NULL
.	NULL

activation	NULL
or	NULL
repression	NULL
of	NULL
target	NULL
genes	NULL
by	NULL
VDR	NULL
.	NULL

Many	NULL
genes	NULL
are	NULL
reportedly	NULL
regulated	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
;	NULL
however	NULL
,	NULL
none	NULL
of	NULL
these	NULL
genes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
direct	NULL
targets	NULL
for	NULL
VDR	NULL
regulation	NULL
.	NULL

Recently	NULL
,	NULL
Liu	NULL
et	NULL
al	NULL
'	NULL
``	NULL
reported	NULL
that	NULL
the	NULL
induced	NULL
differentiation	NULL
of	NULL
the	NULL
myelomonocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
U937	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
facilitated	NULL
by	NULL
transcriptional	NULL
stimulation	NULL
of	NULL
the	NULL
p21W4F/CP	NULL
!	NULL

gene	NULL
by	NULL
VDR	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
but	NULL
not	NULL
all-trans	NULL
RA	NULL
,	NULL
upregulated	NULL
the	NULL
expression	NULL
of	NULL
p21WAr/CP	NULL
!	NULL

and	NULL
p27	NULL
``	NULL
!	NULL

transcripts	NULL
and	NULL
proteins	NULL
in	NULL
RA-resistant	NULL
UF-1	NULL
cells	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

Also	NULL
,	NULL
prior	NULL
studies	NULL
showed	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
did	NULL
not	NULL
increase	NULL
the	NULL
accumulation	NULL
of	NULL
p21WAF/C/P	NULL
!	NULL

mRNA	NULL
in	NULL
RA-responsive	NULL
NB4	NULL
cells	NULL
;	NULL
indeed	NULL
,	NULL
other	NULL
biologic	NULL
effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
NB4	NULL
cells	NULL
may	NULL
occur	NULL
independently	NULL
of	NULL
VDR/VDRE	NULL
action	NULL
.	NULL
``	NULL

''	NULL
Furthermore	NULL
,	NULL
a	NULL
transient	NULL
elevation	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
p21*AF/CIP	NULL
!	NULL

and/or	NULL
p27	NULL
``	NULL
in	NULL
U937	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
enhanced	NULL
the	NULL
expression	NULL
of	NULL
CD11b	NULL
and	NULL
CD14	NULL
antigens	NULL
.	NULL

'Â®	NULL
Consistent	NULL
with	NULL
our	NULL
study	NULL
,	NULL
several	NULL
studies	NULL
have	NULL
linked	NULL
the	NULL
enhanced	NULL
expression	NULL
of	NULL
p21	NULL
*	NULL
``	NULL
``	NULL
in	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
to	NULL
their	NULL
induced	NULL
differentiation	NULL
.	NULL

'**	NULL
>	NULL
These	NULL
data	NULL
suggest	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induces	NULL
increased	NULL
expression	NULL
of	NULL
p21	NULL
%	NULL
A	NULL
``	NULL
``	NULL
``	NULL
``	NULL
and	NULL
p27**	NULL
``	NULL
``	NULL
,	NULL
which	NULL
mediates	NULL
a	NULL
G1	NULL
arrest	NULL
;	NULL
this	NULL
may	NULL
be	NULL
closely	NULL
associated	NULL
with	NULL
the	NULL
terminal	NULL
differentiation	NULL
of	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
edk	NULL
inhibitor	NULL
is	NULL
the	NULL
principal	NULL
mediator	NULL
of	NULL
the	NULL
antiproliferative	NULL
action	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
on	NULL
HL-60	NULL
cells	NULL
,	NULL
by	NULL
showing	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
p27	NULL
``	NULL
but	NULL
not	NULL
correlated	NULL
with	NULL
the	NULL
onset	NULL
of	NULL
G1	NULL
arrest	NULL
.	NULL
``	NULL

We	NULL
found	NULL
in	NULL
UF-1	NULL
cells	NULL
that	NULL
p21	NULL
*	NULL
``	NULL
``	NULL
!	NULL

protein	NULL
levels	NULL
increased	NULL
and	NULL
became	NULL
detectable	NULL
after	NULL
12	NULL
hours	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
treatment	NULL
,	NULL
while	NULL
the	NULL
induction	NULL
of	NULL
p27**	NULL
``	NULL
``	NULL
protein	NULL
was	NULL
much	NULL
more	NULL
gradual	NULL
and	NULL
sustained	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

Also	NULL
,	NULL
all-frans	NULL
RA	NULL
All-trans	NULL
RA	NULL
+	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
Ds	NULL
1,25	NULL
a	NULL
.	NULL

T	NULL
1	NULL
U	NULL
1	NULL
Fig	NULL
7	NULL
.	NULL

Time-dependent	NULL
effects	NULL
of	NULL
either	NULL
0	NULL
3	NULL
6	NULL
420	NULL
24	NULL
48h	NULL
o	NULL
3	NULL
12	NULL
24	NULL
48h	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
RA	NULL
on	NULL
levels	NULL
of	NULL
p27	NULL
``	NULL
mRNA	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
z	NULL
lak	NULL
-	NULL
127	NULL
cultured	NULL
for	NULL
the	NULL
indicated	NULL
durations	NULL
with	NULL
either	NULL
10-	NULL
``	NULL
ha	NULL
.	NULL

Â«	NULL
ee	NULL
Uo	NULL
Â«	NULL
#	NULL
Â»	NULL
.	NULL

Â«	NULL
o	NULL
P	NULL
mol/	NULL
L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
10-7	NULL
mol/L	NULL
RA	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
15	NULL
pg	NULL
per	NULL
lane	NULL
)	NULL
was	NULL
blotted	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
p27	NULL
``	NULL
*	NULL
``	NULL
'	NULL
cDNA	NULL
probe	NULL
.	NULL

Bottom	NULL
panel	NULL
!	NULL

1.0	NULL
1.2	NULL
20	NULL
1.6	NULL
1.4	NULL
14	NULL
1.0	NULL
0.8	NULL
4.0	NULL
3.5	NULL
0.8	NULL
0.4	NULL
Relative	NULL
mRNA	NULL
levels	NULL
shows	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
gel	NULL
with	NULL
28S	NULL
28	NULL
,	NULL
and	NULL
18S	NULL
ribosomal	NULL
RNA	NULL
demonstrating	NULL
equivalent	NULL
S	NULL
RNA-loading	NULL
per	NULL
lane	NULL
.	NULL

Expression	NULL
of	NULL
p27*	NULL
``	NULL
'	NULL
transcripts	NULL
relative	NULL
to	NULL
the	NULL
expression	NULL
in	NULL
control	NULL
cells	NULL
was	NULL
18s	NULL
determined	NULL
by	NULL
densitometry	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

DIFFERENTIATION	NULL
AND	NULL
edk	NULL
INHIBITORS	NULL
hrs	NULL
after	NULL
addition	NULL
of1.2s	NULL
(	NULL
oHpaps	NULL
-_2	NULL
3	NULL
6	NULL
12	NULL
24	NULL
48	NULL
72	NULL
21	NULL
kD	NULL
wou	NULL
qee	NULL
aie	NULL
meer	NULL
mocs	NULL
|	NULL
._..	NULL
Â£321	NULL
hrs	NULL
after	NULL
addition	NULL
of	NULL
1	NULL
,	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
2Ds	NULL
0	NULL
3	NULL
6	NULL
12	NULL
24	NULL
48	NULL
72	NULL
Â«	NULL
Â«	NULL
-	NULL
-	NULL
Â«	NULL
am	NULL
Â»	NULL
am	NULL
Â»	NULL
<	NULL
p	NULL
<	NULL
r	NULL
ite	NULL
|	NULL
<	NULL
-	NULL
|	NULL
2	NULL
/	NULL
.	NULL

sommes	NULL
27	NULL
kD	NULL
alone	NULL
did	NULL
not	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
and	NULL
p27**	NULL
``	NULL
``	NULL
transcripts	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
cooperatively	NULL
enhanced	NULL
the	NULL
levels	NULL
of	NULL
p27	NULL
``	NULL
transcript	NULL
and	NULL
protein	NULL
but	NULL
not	NULL
mRNA	NULL
and	NULL
protein	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
Casaccia-Bonnefil	NULL
et	NULL
al	NULL
``	NULL
reported	NULL
that	NULL
oligodendrocyte	NULL
progenitor	NULL
cells	NULL
derived	NULL
from	NULL
p27*'-knockout	NULL
mice	NULL
showed	NULL
impaired	NULL
growth	NULL
arrest	NULL
and	NULL
differentiation	NULL
after	NULL
removal	NULL
of	NULL
a	NULL
mitogen	NULL
in	NULL
the	NULL
culture	NULL
,	NULL
thus	NULL
demonstrating	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
p27*	NULL
``	NULL
``	NULL
is	NULL
an	NULL
important	NULL
component	NULL
of	NULL
the	NULL
machinery	NULL
required	NULL
for	NULL
the	NULL
GO/G1	NULL
transition	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
exogenous	NULL
expression	NULL
of	NULL
p27*	NULL
``	NULL
``	NULL
in	NULL
HL-60	NULL
cells	NULL
can	NULL
enhance	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
CD11b	NULL
antigen	NULL
,	NULL
demonstrating	NULL
directly	NULL
the	NULL
role	NULL
of	NULL
p27	NULL
``	NULL
in	NULL
cellular	NULL
differentiation	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
p27	NULL
``	NULL
may	NULL
be	NULL
more	NULL
important	NULL
than	NULL
p2	NULL
1	NULL
Â¥AFI/CIP	NULL
!	NULL

for	NULL
the	NULL
G1	NULL
arrest	NULL
and	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
UF-1	NULL
cells	NULL
induced	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

Interestingly	NULL
,	NULL
all-trans	NULL
RA	NULL
greatly	NULL
enhanced	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-induced	NULL
differentiation	NULL
of	NULL
UF-1	NULL
cells	NULL
to	NULL
granulocytes	NULL
,	NULL
whereas	NULL
2231	NULL
B	NULL
1	NULL
,	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
2Ds	NULL
_-	NULL
i-	NULL
i	NULL
All-	NULL
trans	NULL
RA	NULL
21	NULL
kD	NULL
samme	NULL
.	NULL

amman	NULL
|	NULL
Â«	NULL
-1D21	NULL
27	NULL
kD	NULL
Â«	NULL
-	NULL
UID	NULL
|	NULL
-p27	NULL
Fig	NULL
8	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
p21W**	NULL
``	NULL
@	NULL
``	NULL
'	NULL
and	NULL
p27*	NULL
``	NULL
``	NULL
protein	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Total	NULL
cellular	NULL
protein	NULL
(	NULL
10	NULL
pg	NULL
per	NULL
lane	NULL
)	NULL
from	NULL
UF-1	NULL
cells	NULL
treated	NULL
for	NULL
3-72	NULL
hours	NULL
with	NULL
10~	NULL
``	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
12.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
the	NULL
membrane	NULL
.	NULL

p21	NULL
``	NULL
4	NULL
``	NULL
``	NULL
``	NULL
``	NULL
and	NULL
p27	NULL
``	NULL
*	NULL
``	NULL
``	NULL
protein	NULL
levels	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
p21	NULL
``	NULL
4	NULL
``	NULL
``	NULL
``	NULL
``	NULL
and	NULL
p27	NULL
``	NULL
,	NULL
and	NULL
then	NULL
the	NULL
blots	NULL
were	NULL
stained	NULL
with	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
to	NULL
confirm	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
present	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Enhanced	NULL
expression	NULL
of	NULL
p27*	NULL
``	NULL
'	NULL
protein	NULL
by	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
10-	NULL
``	NULL
mol/L	NULL
all-trans	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
48	NULL
hours	NULL
.	NULL

RA	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Although	NULL
all-trans	NULL
RA	NULL
alone	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
G1	NULL
arrest	NULL
of	NULL
UF-1	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
the	NULL
reason	NULL
it	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
cellular	NULL
growth	NULL
is	NULL
unclear	NULL
.	NULL

All-trans	NULL
RA	NULL
alone	NULL
did	NULL
not	NULL
upregulate	NULL
the	NULL
expression	NULL
of	NULL
p21	NULL
AR/CHP	NULL
!	NULL

and	NULL
p27	NULL
``	NULL
!	NULL

in	NULL
UF-1	NULL
cells	NULL
,	NULL
and	NULL
therefore	NULL
,	NULL
induction	NULL
of	NULL
G1	NULL
arrest	NULL
may	NULL
be	NULL
a	NULL
necessary	NULL
,	NULL
but	NULL
insufficient	NULL
,	NULL
condition	NULL
for	NULL
cellular	NULL
differentiation	NULL
in	NULL
UF-1	NULL
cells	NULL
.	NULL

Cell	NULL
cycle	NULL
arrest	NULL
and	NULL
activation	NULL
of	NULL
edk	NULL
inhibitors	NULL
may	NULL
be	NULL
important	NULL
for	NULL
induction	NULL
of	NULL
cellular	NULL
differentiation	NULL
.	NULL

The	NULL
mechanisms	NULL
underlying	NULL
acquired	NULL
RA	NULL
resistance	NULL
in	NULL
APL	NULL
patients	NULL
have	NULL
remained	NULL
elusive	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
mutations	NULL
in	NULL
the	NULL
ligand-binding	NULL
domain	NULL
of	NULL
RARa	NULL
or	NULL
PML/RARa	NULL
genes	NULL
are	NULL
related	NULL
to	NULL
the	NULL
development	NULL
of	NULL
RA	NULL
resistance	NULL
in	NULL
some	NULL
patients	NULL
with	NULL
APL.3	NULL
``	NULL
:38	NULL
Moreover	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
RA	NULL
can	NULL
dissociate	NULL
the	NULL
nuclear	NULL
receptor	NULL
corepressor/histone	NULL
deacetylase	NULL
complex	NULL
from	NULL
PML/RAR	NULL
Â«	NULL
,	NULL
which	NULL
relieves	NULL
transcriptional	NULL
repression	NULL
and	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
terminal	NULL
differentiation	NULL
of	NULL
APL	NULL
cells	NULL
.	NULL
``	NULL

Since	NULL
might	NULL
be	NULL
a	NULL
transcriptional	NULL
target	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2232	NULL
--	NULL
pEGFP-hKIP	NULL
1	NULL
pEGFP-neo	NULL
Relative	NULL
cell	NULL
number	NULL
10Â°	NULL
10	NULL
10	NULL
``	NULL
Fluorescence	NULL
intensity	NULL
Fig	NULL
9	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
for	NULL
markers	NULL
of	NULL
cellular	NULL
differentiation	NULL
on	NULL
p27**'-transfected	NULL
HL-60	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
either	NULL
pEGFP-hKIP1	NULL
or	NULL
pEGFP-neo	NULL
control	NULL
plasmid	NULL
by	NULL
electroporation	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
hours	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
PE-conjugated	NULL
mouse	NULL
anti-human	NULL
CD11b	NULL
antibody	NULL
.	NULL

Expression	NULL
of	NULL
CD11b	NULL
antigen	NULL
in	NULL
the	NULL
GFP-positive	NULL
fraction	NULL
was	NULL
analyzed	NULL
by	NULL
two-color	NULL
flow	NULL
cytometry	NULL
.	NULL

RARs	NULL
,	NULL
a	NULL
RARE	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
was	NULL
required	NULL
to	NULL
confer	NULL
RA-induced	NULL
cellular	NULL
differentiation	NULL
.	NULL
``	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
failure	NULL
to	NULL
induce	NULL
edk	NULL
inhibitors	NULL
by	NULL
the	NULL
ligand-activated	NULL
RAR	NULL
through	NULL
RARE	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
their	NULL
target	NULL
genes	NULL
may	NULL
explain	NULL
,	NULL
in	NULL
part	NULL
,	NULL
the	NULL
RA	NULL
resistance	NULL
in	NULL
UPF-1	NULL
cells	NULL
.	NULL

Further	NULL
studies	NULL
will	NULL
be	NULL
needed	NULL
to	NULL
clarify	NULL
the	NULL
mechanisms	NULL
of	NULL
RA	NULL
resistance	NULL
and	NULL
regulation	NULL
of	NULL
cdk	NULL
inhibitors	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
all-trans	NULL
RA	NULL
enhanced	NULL
p27	NULL
``	NULL
mRNA	NULL
and	NULL
protein	NULL
in	NULL
RA-resistant	NULL
UF-1	NULL
cells	NULL
.	NULL

Our	NULL
group	NULL
and	NULL
others	NULL
have	NULL
already	NULL
reported	NULL
the	NULL
synergistic	NULL
differentiation	NULL
of	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
by	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
which	NULL
was	NULL
probably	NULL
mediated	NULL
through	NULL
their	NULL
cognate	NULL
nuclear	NULL
receptors	NULL
.	NULL
``	NULL

Also	NULL
,	NULL
we	NULL
previously	NULL
found	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
a	NULL
novel	NULL
series	NULL
of	NULL
vitamin	NULL
D	NULL
;	NULL
analogs	NULL
(	NULL
20-epi	NULL
vitamin	NULL
D	NULL
;	NULL
compounds	NULL
)	NULL
and	NULL
9-cis	NULL
RA	NULL
synergistically	NULL
decreased	NULL
proliferation	NULL
and	NULL
induced	NULL
differentiation	NULL
and	NULL
apoptosis	NULL
in	NULL
APL	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
RA	NULL
enhances	NULL
the	NULL
effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
remains	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

RA	NULL
may	NULL
enhance	NULL
the	NULL
transactivation	NULL
capacity	NULL
of	NULL
VDR	NULL
by	NULL
receptor	NULL
heterodimerization	NULL
of	NULL
RAR/VDR	NULL
or	NULL
RXR/V	NULL
DR	NULL
.	NULL

This	NULL
heterodimerization	NULL
may	NULL
lead	NULL
to	NULL
efficient	NULL
transactivation	NULL
of	NULL
edk	NULL
inhibitors	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
role	NULL
of	NULL
the	NULL
APL-specific	NULL
PML/RARa	NULL
Â«	NULL
fusion	NULL
protein	NULL
in	NULL
these	NULL
processes	NULL
should	NULL
be	NULL
explored	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
can	NULL
inhibit	NULL
growth	NULL
in	NULL
the	NULL
G1	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
induce	NULL
differentiation	NULL
of	NULL
UF-1	NULL
RA-resistant	NULL
APL	NULL
cells	NULL
.	NULL

These	NULL
effects	NULL
are	NULL
associated	NULL
with	NULL
an	NULL
increased	NULL
expression	NULL
of	NULL
several	NULL
edk	NULL
inhibitors	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
RA	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
cooperatively	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
cdk	NULL
inhibitors	NULL
,	NULL
GO/G1	NULL
cell	NULL
cycle	NULL
arrest	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
UF-1	NULL
cells	NULL
.	NULL

MUTO	NULL
ET	NULL
AL	NULL
REFERENCES	NULL
1	NULL
.	NULL

Lotan	NULL
R	NULL
:	NULL
Effects	NULL
of	NULL
vitamin	NULL
A	NULL
and	NULL
its	NULL
analogs	NULL
(	NULL
retinoids	NULL
)	NULL
on	NULL
normal	NULL
and	NULL
neoplastic	NULL
cells	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
605:33	NULL
,	NULL
1980	NULL
2	NULL
.	NULL

Douer	NULL
D	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
Retinoic	NULL
acid	NULL
enhances	NULL
growth	NULL
of	NULL
human	NULL
early	NULL
progenitor	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
69:1039	NULL
,	NULL
1982	NULL
3	NULL
.	NULL

Koeffler	NULL
HP	NULL
:	NULL
Induction	NULL
of	NULL
differentiation	NULL
of	NULL
human	NULL
acute	NULL
myelog-enous	NULL
leukemia	NULL
cells	NULL
:	NULL
Therapeutic	NULL
implications	NULL
.	NULL

Blood	NULL
62:709	NULL
,	NULL
1983	NULL
4	NULL
.	NULL

Breitman	NULL
TR	NULL
,	NULL
Selonick	NULL
SE	NULL
,	NULL
Collins	NULL
SJ	NULL
:	NULL
Induction	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
HL-60	NULL
)	NULL
by	NULL
retinoic	NULL
acid	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77:2936	NULL
,	NULL
1980	NULL
5	NULL
.	NULL

Sakashita	NULL
A	NULL
,	NULL
Kizaki	NULL
M	NULL
,	NULL
Pakkala	NULL
S	NULL
,	NULL
Schiller	NULL
G	NULL
,	NULL
Tsuruoka	NULL
N	NULL
,	NULL
Tanosaki	NULL
R	NULL
,	NULL
Cameron	NULL
JF	NULL
,	NULL
Dawson	NULL
MI	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
9-cis-Retinoic	NULL
acid	NULL
:	NULL
Effects	NULL
on	NULL
normal	NULL
and	NULL
leukemic	NULL
hematopoiesis	NULL
in	NULL
vitro	NULL
.	NULL

Blood	NULL
81:1009	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Kizaki	NULL
M	NULL
,	NULL
Ikeda	NULL
Y	NULL
,	NULL
Tanosaki	NULL
R	NULL
,	NULL
Nakajima	NULL
H	NULL
,	NULL
Morikawa	NULL
M	NULL
,	NULL
Sakashita	NULL
A	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
Effects	NULL
of	NULL
novel	NULL
retinoic	NULL
acid	NULL
compound	NULL
,	NULL
9-cis-retinoic	NULL
acid	NULL
,	NULL
on	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor-	NULL
Â«	NULL
and	NULL
retinoid	NULL
X	NULL
receptor-	NULL
Â«	NULL
RNA	NULL
by	NULL
HL-60	NULL
cells	NULL
.	NULL

Blood	NULL
82:3592	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

Abe	NULL
E	NULL
,	NULL
Miyaura	NULL
C	NULL
,	NULL
Sakagami	NULL
H	NULL
,	NULL
Takeda	NULL
M	NULL
,	NULL
Konno	NULL
K	NULL
,	NULL
Yamazaki	NULL
T	NULL
,	NULL
Yoshiki	NULL
S	NULL
,	NULL
Suda	NULL
T	NULL
:	NULL
Differentiation	NULL
of	NULL
mouse	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
induced	NULL
by	NULL
1	NULL
alpha	NULL
,	NULL
25-dihydroxyvitamin	NULL
D	NULL
;	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
78:4990	NULL
,	NULL
1981	NULL
8	NULL
.	NULL

Zhou	NULL
JY	NULL
,	NULL
Norman	NULL
AW	NULL
,	NULL
Chen	NULL
DL	NULL
,	NULL
Sun	NULL
GW	NULL
,	NULL
Uskokovic	NULL
M	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
1,25-Dihydroxy-16-ene-23-yne	NULL
vitamin	NULL
D	NULL
;	NULL
,	NULL
prolongs	NULL
survival	NULL
time	NULL
of	NULL
leukemic	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:3929	NULL
,	NULL
1990	NULL
9	NULL
.	NULL

Evans	NULL
RM	NULL
:	NULL
The	NULL
steroid	NULL
and	NULL
thyroid	NULL
receptor	NULL
superfamily	NULL
.	NULL

Science	NULL
240:889	NULL
,	NULL
1988	NULL
10	NULL
.	NULL

Giguere	NULL
V	NULL
,	NULL
Ong	NULL
ES	NULL
,	NULL
Segui	NULL
P	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
receptor	NULL
for	NULL
the	NULL
morphogen	NULL
retinoic	NULL
acid	NULL
.	NULL

Nature	NULL
330:624	NULL
,	NULL
1987	NULL
11	NULL
.	NULL

Petkovick	NULL
M	NULL
,	NULL
Brand	NULL
NJ	NULL
,	NULL
Krust	NULL
A	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
A	NULL
human	NULL
retinoic	NULL
acid	NULL
receptor	NULL
which	NULL
belongs	NULL
to	NULL
the	NULL
family	NULL
of	NULL
nuclear	NULL
receptors	NULL
.	NULL

Nature	NULL
330:444	NULL
,	NULL
1987	NULL
12	NULL
.	NULL

Baker	NULL
AR	NULL
,	NULL
McDonnell	NULL
DP	NULL
,	NULL
Hughes	NULL
M	NULL
,	NULL
Crisp	NULL
TM	NULL
,	NULL
Mangelsdorf	NULL
DJ	NULL
,	NULL
Haussler	NULL
MR	NULL
,	NULL
Pike	NULL
JW	NULL
,	NULL
Shine	NULL
J	NULL
,	NULL
O'Malley	NULL
BW	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
of	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
human	NULL
vitamin	NULL
D	NULL
receptor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:3294	NULL
,	NULL
1988	NULL
13	NULL
.	NULL

Yu	NULL
VC	NULL
,	NULL
Delsert	NULL
C	NULL
,	NULL
Andersen	NULL
B	NULL
,	NULL
Holloway	NULL
JM	NULL
,	NULL
Devary	NULL
OV	NULL
,	NULL
Naar	NULL
AM	NULL
,	NULL
Kim	NULL
SY	NULL
,	NULL
Boutin	NULL
J-M	NULL
,	NULL
Glass	NULL
CK	NULL
,	NULL
Rosenfeld	NULL
MG	NULL
:	NULL
RXRB	NULL
:	NULL
A	NULL
coregulator	NULL
that	NULL
enhances	NULL
binding	NULL
of	NULL
retinoic	NULL
acid	NULL
,	NULL
thyroid	NULL
hormone	NULL
,	NULL
and	NULL
vitamin	NULL
D	NULL
receptors	NULL
to	NULL
their	NULL
cognate	NULL
response	NULL
elements	NULL
.	NULL

Cell	NULL
67:1251	NULL
,	NULL
1991	NULL
14	NULL
.	NULL

Bugge	NULL
TH	NULL
,	NULL
Pohl	NULL
J	NULL
,	NULL
Lonnoy	NULL
O	NULL
,	NULL
Stunnenberg	NULL
HG	NULL
:	NULL
RXRa	NULL
,	NULL
a	NULL
promiscuous	NULL
partner	NULL
of	NULL
retinoic	NULL
acid	NULL
and	NULL
thyroid	NULL
hormone	NULL
receptors	NULL
.	NULL

EMBO	NULL
J	NULL
11:1409	NULL
,	NULL
1992	NULL
15	NULL
.	NULL

Kliewer	NULL
SA	NULL
,	NULL
Umesono	NULL
K	NULL
,	NULL
Mangelsdorf	NULL
DJ	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Retinoid	NULL
X	NULL
receptor	NULL
interacts	NULL
with	NULL
nuclear	NULL
receptors	NULL
in	NULL
retinoic	NULL
acid	NULL
,	NULL
thyroid	NULL
hormone	NULL
and	NULL
vitamin	NULL
D	NULL
;	NULL
signaling	NULL
.	NULL

Nature	NULL
355:446	NULL
,	NULL
1992	NULL
16	NULL
.	NULL

Jiang	NULL
H	NULL
,	NULL
Lin	NULL
J	NULL
,	NULL
Su	NULL
Z	NULL
,	NULL
Collart	NULL
FR	NULL
,	NULL
Huberman	NULL
E	NULL
,	NULL
Fisher	NULL
PB	NULL
:	NULL
Induction	NULL
of	NULL
differentiation	NULL
in	NULL
human	NULL
promyelocytic	NULL
HL-60	NULL
leukemia	NULL
cells	NULL
activates	NULL
p21	NULL
,	NULL
WAFL/CIP1	NULL
,	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
p53	NULL
.	NULL

Oncogene	NULL
9:3397	NULL
,	NULL
1994	NULL
17	NULL
.	NULL

Schwaller	NULL
J	NULL
,	NULL
Koeffler	NULL
HP	NULL
,	NULL
Niklaus	NULL
G	NULL
,	NULL
Loetscher	NULL
P	NULL
,	NULL
Nagel	NULL
S	NULL
,	NULL
Fey	NULL
MF	NULL
,	NULL
Tobler	NULL
A	NULL
:	NULL
Posttranscriptional	NULL
stabilization	NULL
underlies	NULL
p53-independent	NULL
induction	NULL
of	NULL
in	NULL
differentiating	NULL
human	NULL
leukemic	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
95:973	NULL
,	NULL
1995	NULL
18	NULL
.	NULL

Liu	NULL
M	NULL
,	NULL
Lee	NULL
MH	NULL
,	NULL
Cohen	NULL
M	NULL
,	NULL
Bommakanti	NULL
M	NULL
,	NULL
Freedman	NULL
LP	NULL
:	NULL
Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
edk	NULL
inhibitor	NULL
p21	NULL
by	NULL
vitamin	NULL
Ds	NULL
leads	NULL
to	NULL
the	NULL
induced	NULL
differentiation	NULL
of	NULL
the	NULL
myelomonocytic	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

Genes	NULL
Dev	NULL
10:142	NULL
,	NULL
1996	NULL
19	NULL
.	NULL

Wang	NULL
QM	NULL
,	NULL
Tones	NULL
JB	NULL
,	NULL
Studzinski	NULL
GP	NULL
:	NULL
Cyclin-dependent	NULL
kinase	NULL
inhibitor	NULL
p27	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
the	NULL
G	NULL
;	NULL
-S	NULL
phase	NULL
block	NULL
induced	NULL
by	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
56:264	NULL
,	NULL
1996	NULL
20	NULL
.	NULL

Huang	NULL
ME	NULL
,	NULL
Ye	NULL
UC	NULL
,	NULL
Chen	NULL
SR	NULL
,	NULL
Chai	NULL
JR	NULL
,	NULL
Lu	NULL
JX	NULL
,	NULL
Zhoa	NULL
L	NULL
,	NULL
Gu	NULL
HT	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

DIFFERENTIATION	NULL
AND	NULL
edk	NULL
INHIBITORS	NULL
Wang	NULL
ZY	NULL
:	NULL
Use	NULL
of	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
72:567	NULL
,	NULL
1988	NULL
21	NULL
.	NULL

Castaigne	NULL
S	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Daniel	NULL
MT	NULL
,	NULL
Ballarini	NULL
P	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Fenaux	NULL
P	NULL
,	NULL
Degos	NULL
L	NULL
:	NULL
All-frans	NULL
retinoic	NULL
acid	NULL
as	NULL
a	NULL
differentiation	NULL
therapy	NULL
for	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

I	NULL
.	NULL

Clinical	NULL
results	NULL
.	NULL

Blood	NULL
76:1704	NULL
,	NULL
1990	NULL
22	NULL
.	NULL

Warrell	NULL
RP	NULL
Jr	NULL
,	NULL
Frankel	NULL
SR	NULL
,	NULL
Miller	NULL
WH	NULL
Jr	NULL
,	NULL
Sheinberg	NULL
DA	NULL
,	NULL
Itri	NULL
LM	NULL
,	NULL
WN	NULL
,	NULL
Vyas	NULL
R	NULL
,	NULL
Andreeff	NULL
M	NULL
,	NULL
Tafuri	NULL
A	NULL
,	NULL
Jakubowski	NULL
A	NULL
,	NULL
Gabrilove	NULL
J	NULL
,	NULL
Gordon	NULL
MS	NULL
,	NULL
Dmitrovski	NULL
E	NULL
:	NULL
Differentiation	NULL
therapy	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
with	NULL
tretinoin	NULL
(	NULL
all-frans-retinoic	NULL
acid	NULL
)	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
324:1385	NULL
,	NULL
1991	NULL
23	NULL
.	NULL

Kanamaru	NULL
A	NULL
,	NULL
Takemoto	NULL
Y	NULL
,	NULL
Tanimoto	NULL
M	NULL
,	NULL
Murakami	NULL
H	NULL
,	NULL
Asou	NULL
N	NULL
,	NULL
Kobayashi	NULL
T	NULL
,	NULL
Kuriyama	NULL
K	NULL
,	NULL
Ohmoto	NULL
E	NULL
,	NULL
Sakamaki	NULL
H	NULL
,	NULL
Tsubaki	NULL
K	NULL
,	NULL
Hiraoka	NULL
H	NULL
,	NULL
Yamada	NULL
O	NULL
,	NULL
Oh	NULL
H	NULL
,	NULL
Saito	NULL
K	NULL
,	NULL
Matsuda	NULL
S	NULL
,	NULL
Minato	NULL
K	NULL
,	NULL
Ueda	NULL
T	NULL
,	NULL
Ohno	NULL
R	NULL
:	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
newly	NULL
diagnosed	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
85:1202	NULL
,	NULL
1995	NULL
24	NULL
.	NULL

Warrell	NULL
RP	NULL
Jr	NULL
,	NULL
de	NULL
The	NULL
H	NULL
,	NULL
Wang	NULL
ZY	NULL
,	NULL
Degos	NULL
L	NULL
:	NULL
Acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
329:177	NULL
,	NULL
1993	NULL
25	NULL
.	NULL

Kizaki	NULL
M	NULL
,	NULL
Matsushita	NULL
H	NULL
,	NULL
Takayama	NULL
N	NULL
,	NULL
Muto	NULL
A	NULL
,	NULL
Ueno	NULL
H	NULL
,	NULL
Awaya	NULL
N	NULL
,	NULL
Kawai	NULL
Y	NULL
,	NULL
Asou	NULL
H	NULL
,	NULL
Kamada	NULL
N	NULL
,	NULL
Ikeda	NULL
Y	NULL
:	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
UF-1	NULL
)	NULL
with	NULL
retinoic	NULL
acid-resistant	NULL
features	NULL
.	NULL

Blood	NULL
88:1824	NULL
,	NULL
1996	NULL
26	NULL
.	NULL

Lanotte	NULL
M	NULL
,	NULL
Martin-Thouvenin	NULL
V	NULL
,	NULL
Najman	NULL
S	NULL
,	NULL
Balerini	NULL
P	NULL
,	NULL
ValensiF	NULL
,	NULL
Berger	NULL
R	NULL
:	NULL
NB4	NULL
,	NULL
a	NULL
maturation	NULL
inducible	NULL
cell	NULL
line	NULL
with	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
marker	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
M3	NULL
)	NULL
.	NULL

Blood	NULL
77:1080	NULL
,	NULL
1991	NULL
27	NULL
.	NULL

El-Deiry	NULL
WS	NULL
,	NULL
Tokino	NULL
T	NULL
,	NULL
Velculescu	NULL
VE	NULL
,	NULL
Levy	NULL
DB	NULL
,	NULL
Parsons	NULL
R	NULL
,	NULL
Trent	NULL
JM	NULL
,	NULL
Lin	NULL
D	NULL
,	NULL
Mercer	NULL
WE	NULL
,	NULL
Kinzler	NULL
KW	NULL
,	NULL
Vogelstein	NULL
B	NULL
:	NULL
WAF1	NULL
,	NULL
a	NULL
potential	NULL
mediator	NULL
of	NULL
p53	NULL
tumor	NULL
suppression	NULL
.	NULL

Cell	NULL
75:817	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Polyak	NULL
K	NULL
,	NULL
Lee	NULL
MH	NULL
,	NULL
Erdjument-Bromage	NULL
H	NULL
,	NULL
Koff	NULL
A	NULL
,	NULL
Tempst	NULL
P	NULL
,	NULL
Roberts	NULL
JM	NULL
,	NULL
MassaguÃ©	NULL
J	NULL
:	NULL
Cloning	NULL
of	NULL
p27	NULL
``	NULL
,	NULL
a	NULL
cyclin-cdk	NULL
inhibitor	NULL
and	NULL
a	NULL
potential	NULL
mediator	NULL
of	NULL
extracellular	NULL
antimitogenetic	NULL
signals	NULL
.	NULL

Cell	NULL
78:59	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Bhatia	NULL
M	NULL
,	NULL
Kirkland	NULL
JB	NULL
,	NULL
Meckling-Gill	NULL
KA	NULL
:	NULL
M-CSF	NULL
and	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
synergize	NULL
with	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
to	NULL
induce	NULL
macrophage	NULL
differentiation	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
NB4	NULL
cells	NULL
.	NULL

Leukemia	NULL
8:1744	NULL
,	NULL
1994	NULL
30	NULL
.	NULL

Testa	NULL
U	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Barberi	NULL
T	NULL
,	NULL
Fagioli	NULL
M	NULL
,	NULL
Masciulli	NULL
R	NULL
,	NULL
Ferrucei	NULL
PF	NULL
,	NULL
Seripa	NULL
D	NULL
,	NULL
Camagna	NULL
A	NULL
,	NULL
Alcalay	NULL
M	NULL
,	NULL
Pelicci	NULL
PG	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
PML/RARa*+	NULL
U937	NULL
mutant	NULL
and	NULL
NB4	NULL
cell	NULL
lines	NULL
:	NULL
Retinoic	NULL
acid	NULL
restores	NULL
the	NULL
monocytic	NULL
differentiation	NULL
response	NULL
to	NULL
vitamin	NULL
Ds	NULL
.	NULL

Cancer	NULL
Res	NULL
54:4508	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Warrell	NULL
RP	NULL
Jr	NULL
:	NULL
Retinoid	NULL
resistance	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
:	NULL
New	NULL
mechanisms	NULL
,	NULL
strategies	NULL
,	NULL
and	NULL
implications	NULL
.	NULL

Blood	NULL
82	NULL
:	NULL
1949	NULL
,	NULL
1993	NULL
32	NULL
.	NULL

Kizaki	NULL
M	NULL
,	NULL
Ueno	NULL
H	NULL
,	NULL
Yamazoe	NULL
Y	NULL
,	NULL
Shimada	NULL
M	NULL
,	NULL
Takayama	NULL
N	NULL
,	NULL
Muto	NULL
A	NULL
,	NULL
Matsushita	NULL
H	NULL
,	NULL
Nakajima	NULL
H	NULL
,	NULL
Morikawa	NULL
M	NULL
,	NULL
Koeffler	NULL
HP	NULL
,	NULL
Ikeda	NULL
Y	NULL
:	NULL
Mechanisms	NULL
of	NULL
retinoid	NULL
resistance	NULL
in	NULL
leukemic	NULL
cells	NULL
:	NULL
Possible	NULL
role	NULL
of	NULL
cytochrome	NULL
P450	NULL
and	NULL
P-glycoprotein	NULL
.	NULL

Blood	NULL
87:725	NULL
,	NULL
1996	NULL
33	NULL
.	NULL

Furukawa	NULL
Y	NULL
,	NULL
Uenoyama	NULL
S	NULL
,	NULL
Ohta	NULL
M	NULL
,	NULL
Tsunoda	NULL
A	NULL
,	NULL
Griffin	NULL
JD	NULL
,	NULL
Saito	NULL
M	NULL
:	NULL
Transforming	NULL
growth	NULL
factor-B	NULL
inhibits	NULL
phosphorylation	NULL
of	NULL
the	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
product	NULL
in	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
Josk-1	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:17121	NULL
,	NULL
1992	NULL
34	NULL
.	NULL

Zhang	NULL
W	NULL
,	NULL
Grasso	NULL
L	NULL
,	NULL
McClain	NULL
CD	NULL
,	NULL
Gambel	NULL
AM	NULL
,	NULL
Cha	NULL
Y	NULL
,	NULL
Travali	NULL
S	NULL
,	NULL
Deisseroth	NULL
AB	NULL
,	NULL
Mercer	NULL
WE	NULL
:	NULL
p53-Independent	NULL
induction	NULL
of	NULL
WAFI/CIP	NULL
]	NULL
in	NULL
human	NULL
leukemia	NULL
cells	NULL
is	NULL
correlated	NULL
with	NULL
growth	NULL
arrest	NULL
accompanying	NULL
monocyte/macrophage	NULL
differentiation	NULL
.	NULL

Cancer	NULL
Res	NULL
55:668	NULL
,	NULL
1995	NULL
2233	NULL
35	NULL
.	NULL

Bhatia	NULL
M	NULL
,	NULL
Kirkland	NULL
JB	NULL
,	NULL
Meckling-Gill	NULL
KA	NULL
:	NULL
Monocytic	NULL
differentiation	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
is	NULL
independent	NULL
of	NULL
nuclear	NULL
receptor	NULL
binding	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:15962	NULL
,	NULL
1995	NULL
36	NULL
.	NULL

Casaccia-Bonnefil	NULL
P	NULL
,	NULL
Tikoo	NULL
R	NULL
,	NULL
Kiyokawa	NULL
H	NULL
,	NULL
Friedrich	NULL
V	NULL
,	NULL
Chao	NULL
MV	NULL
,	NULL
Koff	NULL
A	NULL
:	NULL
Oligodendrocyte	NULL
precursor	NULL
differentiation	NULL
is	NULL
perturbed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
cyclin-dependent	NULL
kinase	NULL
inhibitor	NULL
p27	NULL
``	NULL
.	NULL

Genes	NULL
Dev	NULL
11:2335	NULL
,	NULL
1997	NULL
37	NULL
.	NULL

Imaizumi	NULL
M	NULL
,	NULL
Suzuki	NULL
H	NULL
,	NULL
Yoshinari	NULL
M	NULL
,	NULL
Sato	NULL
A	NULL
,	NULL
Saito	NULL
T	NULL
,	NULL
Sugawara	NULL
A	NULL
,	NULL
Tsuchiya	NULL
S	NULL
,	NULL
Hatae	NULL
Y	NULL
,	NULL
Fujimoto	NULL
T	NULL
,	NULL
Kakizuka	NULL
A	NULL
,	NULL
Konno	NULL
T	NULL
,	NULL
Iinuma	NULL
K	NULL
:	NULL
Mutations	NULL
in	NULL
the	NULL
E-domain	NULL
of	NULL
RARa	NULL
Â«	NULL
portion	NULL
of	NULL
the	NULL
PML/RARa	NULL
chimeric	NULL
gene	NULL
may	NULL
confer	NULL
clinical	NULL
resistance	NULL
to	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
92:374	NULL
,	NULL
1998	NULL
38	NULL
.	NULL

Ding	NULL
W	NULL
,	NULL
Li	NULL
Y-P	NULL
,	NULL
Nobile	NULL
LM	NULL
,	NULL
Grills	NULL
G	NULL
,	NULL
Carrera	NULL
I	NULL
,	NULL
Paictta	NULL
E	NULL
,	NULL
Tallman	NULL
MS	NULL
,	NULL
Wierik	NULL
PH	NULL
,	NULL
Gallagher	NULL
RE	NULL
:	NULL
Leukemic	NULL
cellular	NULL
retinoic	NULL
acid	NULL
resistance	NULL
and	NULL
missense	NULL
mutations	NULL
in	NULL
the	NULL
PML-RARa	NULL
fusion	NULL
gene	NULL
after	NULL
relapse	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
from	NULL
treatment	NULL
with	NULL
all-frans	NULL
retinoic	NULL
acid	NULL
and	NULL
intensive	NULL
chemotherapy	NULL
.	NULL

Blood	NULL
92:1172	NULL
,	NULL
1998	NULL
39	NULL
.	NULL

Lin	NULL
RJ	NULL
,	NULL
Nagy	NULL
L	NULL
,	NULL
Inoue	NULL
S	NULL
,	NULL
Shao	NULL
W	NULL
,	NULL
Miller	NULL
WH	NULL
Jr	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Role	NULL
of	NULL
the	NULL
histone	NULL
deacetylase	NULL
complex	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukaemia	NULL
.	NULL

Nature	NULL
391:811	NULL
,	NULL
1998	NULL
40	NULL
.	NULL

Grignani	NULL
F	NULL
,	NULL
Matteis	NULL
SD	NULL
,	NULL
Nervi	NULL
C	NULL
,	NULL
Tomassoni	NULL
L	NULL
,	NULL
Gelmefti	NULL
V	NULL
,	NULL
Cioce	NULL
M	NULL
,	NULL
Fanelli	NULL
M	NULL
,	NULL
Ruthardt	NULL
M	NULL
,	NULL
Ferrara	NULL
FF	NULL
,	NULL
Lazar	NULL
MA	NULL
,	NULL
Minucci	NULL
S	NULL
,	NULL
Pellicci	NULL
PG	NULL
:	NULL
Fusion	NULL
proteins	NULL
of	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor-	NULL
Â«	NULL
recruit	NULL
histone	NULL
deacetylase	NULL
in	NULL
promyelocytic	NULL
leukaemia	NULL
.	NULL

Nature	NULL
391:815	NULL
,	NULL
1998	NULL
41	NULL
.	NULL

He	NULL
L-Z	NULL
,	NULL
Guidez	NULL
F	NULL
,	NULL
Tribioli	NULL
C	NULL
,	NULL
Peruzzi	NULL
D	NULL
,	NULL
Ruthardt	NULL
M	NULL
,	NULL
Zelent	NULL
A	NULL
,	NULL
Pandolfi	NULL
PP	NULL
:	NULL
Distinct	NULL
interactions	NULL
of	NULL
PML-RARa	NULL
Â«	NULL
and	NULL
PLZF-RARa	NULL
with	NULL
co-repressors	NULL
determine	NULL
differential	NULL
responses	NULL
to	NULL
RA	NULL
in	NULL
APL	NULL
.	NULL

Nat	NULL
Genet	NULL
18:126	NULL
,	NULL
1998	NULL
42	NULL
.	NULL

Guidez	NULL
F	NULL
,	NULL
Ivins	NULL
S	NULL
,	NULL
Zhu	NULL
J	NULL
,	NULL
Soderstrom	NULL
M	NULL
,	NULL
Waxman	NULL
S	NULL
,	NULL
Zelent	NULL
A	NULL
:	NULL
Reduced	NULL
retinoic	NULL
acid-sensitivities	NULL
of	NULL
nuclear	NULL
receptor	NULL
corepressor	NULL
binding	NULL
to	NULL
PML	NULL
-	NULL
and	NULL
PLZF-RARe	NULL
Â«	NULL
underlie	NULL
molecular	NULL
pathogenesis	NULL
and	NULL
treatment	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
91:2634	NULL
,	NULL
1998	NULL
43	NULL
.	NULL

Liu	NULL
M	NULL
,	NULL
Iavarone	NULL
A	NULL
,	NULL
Freedman	NULL
LP	NULL
:	NULL
Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
p21W4	NULL
``	NULL
``	NULL
``	NULL
``	NULL
gene	NULL
by	NULL
retinoic	NULL
acid	NULL
receptor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:31723	NULL
,	NULL
1996	NULL
44	NULL
.	NULL

Nakajima	NULL
H	NULL
,	NULL
Kizaki	NULL
M	NULL
,	NULL
Ueno	NULL
H	NULL
,	NULL
Muto	NULL
A	NULL
,	NULL
Takayama	NULL
N	NULL
,	NULL
Matsushita	NULL
H	NULL
,	NULL
Sonoda	NULL
A	NULL
,	NULL
Ikeda	NULL
Y	NULL
:	NULL
All-frans	NULL
and	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
enhance	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
-induced	NULL
monocytic	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
.	NULL

Leuk	NULL
Res	NULL
20:665	NULL
,	NULL
1996	NULL
45	NULL
.	NULL

Defacque	NULL
H	NULL
,	NULL
Commes	NULL
T	NULL
,	NULL
Sevilla	NULL
C	NULL
,	NULL
Rochette-Egly	NULL
C	NULL
,	NULL
Marti	NULL
J	NULL
:	NULL
Synergistic	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
by	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
and	NULL
D	NULL
;	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
retinoid	NULL
X	NULL
receptor	NULL
Â«	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
203:272	NULL
,	NULL
1994	NULL
46	NULL
.	NULL

Masciulli	NULL
R	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Barberi	NULL
T	NULL
,	NULL
Samoggia	NULL
P	NULL
,	NULL
Tritarelli	NULL
E	NULL
,	NULL
Pustorino	NULL
R	NULL
,	NULL
Mastroberardino	NULL
G	NULL
,	NULL
Camagna	NULL
A	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Combined	NULL
vitamin	NULL
D	NULL
Â»	NULL
/retinoic	NULL
acid	NULL
induction	NULL
of	NULL
human	NULL
promyelocytic	NULL
cell	NULL
lines	NULL
:	NULL
Enhanced	NULL
phagocytic	NULL
cell	NULL
maturation	NULL
and	NULL
hybrid	NULL
granulocytic	NULL
pheno-type	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
6:493	NULL
,	NULL
1995	NULL
47	NULL
.	NULL

Elstner	NULL
E	NULL
,	NULL
Linker-Israeli	NULL
M	NULL
,	NULL
Le	NULL
J	NULL
,	NULL
Umiel	NULL
T	NULL
,	NULL
Michl	NULL
P	NULL
,	NULL
Said	NULL
JW	NULL
,	NULL
Binderup	NULL
L	NULL
,	NULL
Reed	NULL
JC	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
Synergistic	NULL
decrease	NULL
of	NULL
clonal	NULL
proliferation	NULL
,	NULL
induction	NULL
of	NULL
differentiation	NULL
,	NULL
and	NULL
apoptosis	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
after	NULL
combined	NULL
treatment	NULL
with	NULL
novel	NULL
20-epi	NULL
vitamin	NULL
D	NULL
;	NULL
analogs	NULL
and	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
99:349	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Â®	NULL
blO	NULL
0d	NULL
1999	NULL
93	NULL
:	NULL
2225-2233	NULL
1,25-Dihydroxyvitamin	NULL
D4	NULL
Induces	NULL
Differentiation	NULL
of	NULL
a	NULL
Retinoic	NULL
Acid	NULL
ReS|stant	NULL
Acute	NULL
Pr	NULL
Leukemi	NULL
II	NULL
Line	NULL
(	NULL
UF-1	NULL
)	NULL
Associated	NULL
With	NULL
Expression	NULL
of	NULL
p21	NULL
WXï¬I	NULL
708	NULL
}	NULL
;	NULL
fand	NULL
p27	NULL
ï¬g	NULL
?	NULL

Akihiro	NULL
Muto	NULL
,	NULL
Masahiro	NULL
Kizaki	NULL
,	NULL
Kenji	NULL
Yamato	NULL
,	NULL
Yohko	NULL
Kawai	NULL
,	NULL
Maiko	NULL
Kamata-Matsushita	NULL
,	NULL
Hironori	NULL
Ueno	NULL
,	NULL
Masahiro	NULL
Ohguchi	NULL
,	NULL
Tatsuji	NULL
Nishihara	NULL
,	NULL
H.	NULL
Phillip	NULL
Koeffler	NULL
and	NULL
Yasuo	NULL
Ikeda	NULL
p	NULL
_	NULL
o	NULL
a	NULL
'	NULL
~	NULL
,	NULL
Â©1004	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/93/7/2225.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

